7Baggers

Cardinal Health, Inc
(NYSE:CAH) 

CAH stock logo

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company ope...

Founded: 1971
Full Time Employees: 48,000
CEO: Jason Hollar  
Sector: Healthcare
Industry: Medical Distribution

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 
                                                                                        
      revenue
    60,940,000,000 65,627,000,000 64,009,000,000 60,159,000,000 54,878,000,000 55,264,000,000 52,277,000,000 59,708,000,000 54,911,000,000 57,445,000,000 54,763,000,000 53,453,000,000 50,487,000,000 51,469,000,000 49,603,000,000 47,103,000,000 44,836,000,000 45,457,000,000 43,968,000,000 42,586,000,000 39,275,000,000 41,541,000,000 39,065,000,000 36,689,000,000 39,157,000,000 39,735,000,000 37,341,000,000 37,353,000,000 35,228,000,000 37,740,000,000 35,213,000,000 35,349,000,000 33,633,000,000 35,186,000,000 32,641,000,000 32,966,000,000 31,821,000,000 33,150,000,000 32,039,000,000 31,384,000,000 30,662,000,000 31,445,000,000 28,055,000,000 27,548,000,000 25,375,000,000 25,537,000,000 24,070,000,000 22,894,000,000 21,427,000,000 22,240,000,000 24,523,000,000 25,420,000,000 24,552,000,000 25,232,000,000 25,889,000,000 26,764,500,000 26,917,500,000 27,078,000,000 26,792,000,000 26,763,500,000 26,071,400,000 25,371,800,000 24,437,500,000 24,459,600,000 24,342,800,000 24,919,700,000 24,780,700,000 25,127,000,000 24,938,700,000 25,099,500,000 24,347,200,000 22,925,600,000 22,909,600,000 23,282,700,000 21,973,400,000 22,262,900,000 21,867,100,000 21,784,600,000 21,356,700,000 21,708,300,000 20,637,500,000 19,919,000,000 19,373,400,000  
      yoy
    11.05% 18.75% 22.44% 0.76% -0.06% -3.80% -4.54% 11.70% 8.76% 11.61% 10.40% 13.48% 12.60% 13.23% 12.82% 10.61% 14.16% 9.43% 12.55% 16.07% 0.30% 4.55% 4.62% -1.78% 11.15% 5.29% 6.04% 5.67% 4.74% 7.26% 7.88% 7.23% 5.69% 6.14% 1.88% 5.04% 3.78% 5.42% 14.20% 13.92% 20.84% 23.14% 16.56% 20.33% 18.43% 14.82% -1.85% -9.94% -12.73% -11.86% -5.28% -5.02% -8.79% -6.82% -3.37% 0.00% 3.25% 6.72% 9.63% 9.42% 7.10% 1.81% -1.38% -2.66% -2.39% -0.72% 1.78% 9.60% 8.86% 7.80% 10.80% 2.98% 4.77% 6.88% 2.89% 2.55% 5.96% 9.37% 10.24%      
      qoq
    -7.14% 2.53% 6.40% 9.62% -0.70% 5.71% -12.45% 8.74% -4.41% 4.90% 2.45% 5.87% -1.91% 3.76% 5.31% 5.06% -1.37% 3.39% 3.25% 8.43% -5.45% 6.34% 6.48% -6.30% -1.45% 6.41% -0.03% 6.03% -6.66% 7.18% -0.38% 5.10% -4.41% 7.80% -0.99% 3.60% -4.01% 3.47% 2.09% 2.35% -2.49% 12.08% 1.84% 8.56% -0.63% 6.09% 5.14% 6.85% -3.66% -9.31% -3.53% 3.54% -2.69% -2.54% -3.27% -0.57% -0.59% 1.07% 0.11% 2.65% 2.76% 3.82% -0.09% 0.48% -2.32% 0.56% -1.38% 0.76% -0.64% 3.09% 6.20% 0.07% -1.60% 5.96% -1.30% 1.81% 0.38% 2.00% -1.62% 5.19% 3.61% 2.82%   
      cost of products sold
    58,442,000,000 63,230,000,000 61,690,000,000 57,957,000,000 52,755,000,000 53,323,000,000 50,375,000,000 57,855,000,000 52,964,000,000 55,599,000,000 52,995,000,000 51,626,000,000 48,702,000,000 49,806,000,000 47,989,000,000 45,498,000,000 43,154,000,000 43,841,000,000 42,326,000,000 41,111,000,000 37,463,000,000 39,765,000,000 37,350,000,000 35,099,000,000 37,272,000,000 38,021,000,000 35,662,000,000 35,679,000,000 33,464,000,000 36,010,000,000 33,546,000,000 33,614,000,000 31,720,000,000 33,325,000,000 30,969,000,000 31,343,000,000 30,093,000,000 31,548,000,000 30,449,000,000 29,718,000,000 28,973,000,000 29,836,000,000 26,476,000,000 26,090,000,000 23,916,000,000 24,083,000,000 22,729,000,000 21,638,000,000 20,130,000,000 20,895,000,000 23,259,000,000 24,172,000,000 23,261,000,000 24,008,000,000 24,730,000,000 25,628,500,000 25,710,800,000 25,964,100,000 25,707,500,000 25,720,200,000 24,909,200,000 24,377,600,000 23,475,300,000 23,555,500,000 23,332,700,000 23,962,000,000 23,871,900,000 23,783,200,000 23,537,000,000 23,683,100,000 22,982,700,000 21,456,200,000 21,441,800,000 21,928,100,000 20,631,200,000 20,905,400,000 20,479,600,000 20,484,700,000 20,057,800,000 20,280,900,000 19,268,300,000 18,611,800,000 18,160,200,000  
      gross margin
    2,498,000,000 2,397,000,000 2,319,000,000 2,202,000,000 2,123,000,000 1,941,000,000 1,902,000,000 1,853,000,000 1,947,000,000 1,846,000,000 1,768,000,000 1,827,000,000 1,785,000,000 1,663,000,000 1,614,000,000 1,605,000,000 1,682,000,000 1,616,000,000 1,642,000,000 1,475,000,000 1,812,000,000 1,776,000,000 1,715,000,000 1,590,000,000 1,885,000,000 1,714,000,000 1,679,000,000 1,674,000,000 1,764,000,000 1,730,000,000 1,667,000,000 1,735,000,000 1,913,000,000 1,861,000,000 1,672,000,000 1,623,000,000 1,728,000,000 1,602,000,000 1,590,000,000 1,666,000,000 1,689,000,000 1,609,000,000 1,579,000,000 1,458,000,000 1,459,000,000 1,454,000,000 1,341,000,000 1,256,000,000 1,297,000,000 1,345,000,000 1,264,000,000 1,248,000,000 1,291,000,000 1,224,000,000 1,159,000,000 1,136,000,000 1,206,700,000 1,113,900,000 1,084,500,000 1,043,300,000 1,162,200,000 994,200,000 962,200,000 904,100,000 1,010,100,000 957,700,000 908,800,000 1,343,800,000 1,401,700,000 1,416,400,000 1,364,500,000 1,469,400,000 1,467,800,000 1,354,600,000 1,342,200,000 1,357,500,000 1,387,500,000 1,299,900,000 1,298,900,000 1,427,400,000 1,369,200,000 1,307,200,000 1,213,200,000  
      yoy
    17.66% 23.49% 21.92% 18.83% 9.04% 5.15% 7.58% 1.42% 9.08% 11.00% 9.54% 13.83% 6.12% 2.91% -1.71% 8.81% -7.17% -9.01% -4.26% -7.23% -3.87% 3.62% 2.14% -5.02% 6.86% -0.92% 0.72% -3.52% -7.79% -7.04% -0.30% 6.90% 10.71% 16.17% 5.16% -2.58% 2.31% -0.44% 0.70% 14.27% 15.76% 10.66% 17.75% 16.08% 12.49% 8.10% 6.09% 0.64% 0.46% 9.89% 9.06% 9.86% 6.99% 9.88% 6.87% 8.89% 3.83% 12.04% 12.71% 15.40% 15.06% 3.81% 5.88% -32.72% -27.94% -32.38% -33.40% -8.55% -4.50% 4.56% 1.66% 8.24% 5.79% 4.21% 3.33% -4.90% 1.34% -0.56% 7.06%      
      qoq
    4.21% 3.36% 5.31% 3.72% 9.38% 2.05% 2.64% -4.83% 5.47% 4.41% -3.23% 2.35% 7.34% 3.04% 0.56% -4.58% 4.08% -1.58% 11.32% -18.60% 2.03% 3.56% 7.86% -15.65% 9.98% 2.08% 0.30% -5.10% 1.97% 3.78% -3.92% -9.30% 2.79% 11.30% 3.02% -6.08% 7.87% 0.75% -4.56% -1.36% 4.97% 1.90% 8.30% -0.07% 0.34% 8.43% 6.77% -3.16% -3.57% 6.41% 1.28% -3.33% 5.47% 5.61% 2.02% -5.86% 8.33% 2.71% 3.95% -10.23% 16.90% 3.33% 6.43% -10.49% 5.47% 5.38% -32.37% -4.13% -1.04% 3.80% -7.14% 0.11% 8.36% 0.92% -1.13% -2.16% 6.74% 0.08% -9.00% 4.25% 4.74% 7.75%   
      gross margin %
    4.10% 3.65% 3.62% 3.66% 3.87% 3.51% 3.64% 3.10% 3.55% 3.21% 3.23% 3.42% 3.54% 3.23% 3.25% 3.41% 3.75% 3.56% 3.73% 3.46% 4.61% 4.28% 4.39% 4.33% 4.81% 4.31% 4.50% 4.48% 5.01% 4.58% 4.73% 4.91% 5.69% 5.29% 5.12% 4.92% 5.43% 4.83% 4.96% 5.31% 5.51% 5.12% 5.63% 5.29% 5.75% 5.69% 5.57% 5.49% 6.05% 6.05% 5.15% 4.91% 5.26% 4.85% 4.48% 4.24% 4.48% 4.11% 4.05% 3.90% 4.46% 3.92% 3.94% 3.70% 4.15% 3.84% 3.67% 5.35% 5.62% 5.64% 5.60% 6.41% 6.41% 5.82% 6.11% 6.10% 6.35% 5.97% 6.08% 6.58% 6.63% 6.56% 6.26%  
      operating expenses:
                                                                                        
      distribution, selling, general and administrative expenses
    1,542,000,000 1,504,000,000 1,461,000,000 974,500,000 1,315,000,000 1,306,000,000 1,277,000,000 1,238,000,000 1,282,000,000 1,283,000,000 1,197,000,000 1,267,000,000 1,179,000,000 1,191,000,000 1,197,000,000 1,155,000,000 1,137,000,000 1,151,000,000 1,114,000,000 1,129,000,000 1,120,000,000 1,147,000,000 1,137,000,000 1,137,000,000 1,165,000,000 1,163,000,000 1,107,000,000 1,165,000,000 1,097,000,000 1,064,000,000 1,155,000,000 1,271,000,000 1,132,000,000 1,131,000,000 1,062,000,000 983,000,000 960,000,000       847,000,000 803,000,000 815,000,000 775,000,000 795,000,000 736,000,000 766,000,000 732,000,000 776,000,000 712,000,000 699,000,000 690,000,000    643,300,000    591,900,000 588,200,000 628,600,000 605,200,000 586,100,000                  
      restructuring and employee severance
    25,000,000 21,000,000 20,000,000 27,000,000 28,000,000 9,000,000 24,000,000 69,000,000 53,000,000 28,000,000 25,000,000 33,000,000 16,000,000 17,000,000 29,000,000 45,000,000 31,000,000 7,000,000 18,000,000 33,000,000 24,000,000 20,000,000 37,000,000 42,000,000 -6,000,000 56,000,000 30,000,000 28,000,000 53,000,000 12,000,000 32,000,000 21,000,000 2,000,000 21,000,000 132,000,000 25,000,000 15,000,000 7,000,000 9,000,000 6,000,000 6,000,000 2,000,000 12,000,000 11,000,000 7,000,000 7,000,000 19,000,000 6,000,000 5,000,000 10,000,000 11,000,000 32,000,000 33,000,000 1,000,000 5,000,000 8,800,000 7,100,000 1,700,000 3,400,000 4,900,000 6,200,000 2,600,000 1,800,000 6,300,000 13,900,000 10,700,000 59,700,000                  
      amortization and other acquisition-related costs
    114,000,000 130,000,000 104,000,000 133,000,000 152,000,000 105,000,000 74,000,000 77,000,000 80,000,000 63,000,000 64,000,000 69,000,000 74,000,000 71,000,000 71,000,000 87,000,000 79,000,000 79,000,000 79,000,000 106,000,000 111,000,000 116,000,000 118,000,000 129,000,000 130,000,000 133,000,000 132,000,000 153,000,000 154,000,000 157,000,000 156,000,000 164,000,000 175,000,000 184,000,000 183,000,000 162,000,000 128,000,000 115,000,000 122,000,000 132,000,000 108,000,000 114,000,000 105,000,000 91,000,000 77,000,000 60,000,000 53,000,000 63,000,000 56,000,000 56,000,000 49,000,000                                  
      acquisition-related cash and share-based compensation costs
    112,000,000 67,000,000 64,000,000 106,000,000 20,000,000                                                                                
      impairments and loss on disposal of assets
    185,000,000 -14,000,000 2,000,000 33,000,000 -17,000,000 3,000,000 -1,000,000 12,000,000 84,000,000 1,000,000 537,000,000 367,000,000 20,000,000 710,000,000 153,000,000 286,000,000 471,000,000 1,295,000,000 -2,000,000 1,000,000 69,000,000  9,000,000  -1,000,000 7,000,000 1,000,000       68,000,000  3,750,000 2,000,000 9,000,000      -4,750,000 -1,000,000 -18,000,000  5,000,000  9,000,000  832,000,000 21,000,000 5,000,000 1,000,000 1,600,000 17,100,000                            
      litigation (recoveries)/charges
    11,000,000 -18,000,000  -9,000,000 -105,000,000 -31,000,000 -40,000,000 49,000,000 81,000,000 -11,000,000 -41,000,000 -46,000,000 -76,000,000 -207,000,000 27,000,000 -4,000,000 61,000,000 34,000,000 18,000,000 44,000,000 15,000,000 32,000,000 1,038,000,000 12,000,000 35,000,000 21,000,000 5,673,000,000 16,000,000 17,000,000 -15,000,000 19,000,000 4,000,000 64,000,000 58,000,000 32,000,000 11,000,000 18,000,000 19,000,000 1,000,000 -66,000,000 5,000,000 -9,000,000  -49,000,000 -18,000,000 44,000,000 28,000,000  -8,000,000 -15,000,000 1,000,000 -1,000,000 -3,000,000 -12,000,000 -22,000,000 200,000 -200,000 100,000 -3,200,000                          
      operating earnings
    509,000,000 707,000,000 668,000,000 428,000,000 730,000,000 549,000,000 568,000,000 408,000,000 367,000,000 482,000,000 -14,000,000 137,000,000 572,000,000 -119,000,000 137,000,000 36,000,000 -97,000,000 -950,000,000 415,000,000 162,000,000 473,000,000 461,000,000  270,000,000 562,000,000 334,000,000 -5,264,000,000 308,000,000 432,000,000 504,000,000 816,000,000 -1,080,000,000 546,000,000 399,000,000 262,000,000 439,000,000 605,000,000 542,000,000 535,000,000 620,000,000 656,000,000 563,000,000 620,000,000 558,000,000 591,000,000 546,000,000 466,000,000 387,000,000 508,000,000 519,000,000 471,000,000 -443,000,000 475,000,000 506,000,000 457,000,000 403,800,000 526,600,000 449,300,000 412,300,000 358,900,000 447,300,000 343,900,000 363,900,000 333,900,000 366,300,000 366,800,000 239,900,000 425,200,000 496,300,000 537,900,000 426,300,000 535,700,000 576,500,000 519,200,000 489,800,000 420,600,000 -9,800,000 512,100,000 463,700,000 534,300,000 559,400,000 484,400,000 372,400,000  
      other expense
    16,000,000 -11,000,000 -10,000,000 -30,000,000 -9,000,000 3,000,000 -5,000,000 16,000,000 -7,000,000 -16,000,000 -2,000,000 1,000,000  -7,000,000 2,000,000 30,000,000 3,000,000 -13,000,000 -4,000,000 -16,000,000 -12,000,000 -12,000,000 -7,000,000 -22,000,000 19,000,000 -12,000,000 14,000,000         -500,000 -5,000,000                  -8,000,000   800,000 3,800,000     2,200,000 -1,400,000 -25,600,000 -8,900,000                  
      interest expense
    101,000,000 88,000,000 80,000,000 74,000,000 74,000,000 35,000,000 32,000,000 -4,000,000 33,000,000 8,000,000 14,000,000 15,000,000 28,000,000 25,000,000 25,000,000 34,000,000 38,000,000 37,000,000 40,000,000 44,000,000 45,000,000 46,000,000 45,000,000 49,000,000 60,000,000 63,000,000 66,000,000 67,000,000 75,000,000 76,000,000 77,000,000 78,000,000 84,000,000 87,000,000 81,000,000 67,000,000 46,000,000 44,000,000 44,000,000 44,000,000 44,000,000 45,000,000 44,000,000 36,000,000 35,000,000 36,000,000 34,000,000 33,000,000 34,000,000 33,000,000 33,000,000 36,000,000 34,000,000 27,000,000 26,000,000 24,800,000 23,900,000 22,900,000 23,500,000 23,800,000 25,100,000 21,900,000 22,000,000 24,600,000 27,700,000 27,400,000 33,900,000                  
      earnings before income taxes
    392,000,000 630,000,000 598,000,000 384,000,000 665,000,000 511,000,000 541,000,000 396,000,000 341,000,000 490,000,000 -26,000,000 121,000,000 544,000,000  110,000,000 -28,000,000 -137,000,000 -973,000,000 369,000,000 119,000,000 440,000,000 427,000,000  815,000,000 478,000,000 279,000,000 -5,344,000,000 239,000,000 370,000,000 407,000,000 736,000,000 239,750,000 464,000,000 317,000,000 178,000,000 387,250,000 564,000,000 491,000,000 494,000,000 425,000,000 612,000,000 520,000,000 568,000,000                                          
      provision for income taxes
    12,000,000 159,000,000 144,000,000 141,000,000 157,000,000 110,000,000 124,000,000 162,000,000 82,000,000 136,000,000  187,000,000 197,000,000  -1,000,000 -165,000,000 1,253,000,000  97,000,000 4,000,000 320,000,000 -203,000,000 -410,000,000 158,000,000 127,000,000 59,000,000 -423,000,000         133,250,000 182,000,000       131,000,000 193,000,000 162,000,000 169,000,000   217,000,000  105,000,000 101,000,000  167,000,000 140,900,000 177,900,000 161,200,000 147,900,000 133,900,000 175,600,000 112,800,000 129,800,000 114,600,000 138,400,000 134,800,000 236,800,000 131,100,000 122,400,000 156,600,000 114,100,000 166,700,000 179,500,000 144,100,000 143,700,000 163,700,000 -37,100,000 164,000,000 115,700,000 162,200,000 169,200,000 146,500,000 106,100,000  
      net earnings
    380,000,000 471,000,000 454,000,000 243,000,000 508,000,000 401,000,000 417,000,000 234,000,000 259,000,000 354,000,000 6,000,000 -66,000,000 347,000,000 -130,000,000 111,000,000 137,000,000 -1,390,000,000 49,000,000 272,000,000 115,000,000 120,000,000 630,000,000  657,000,000 351,000,000 220,000,000 -4,921,000,000 195,000,000 296,000,000 281,000,000 594,000,000 -1,166,000,000 255,000,000 1,053,000,000 117,000,000 278,000,000 382,000,000 324,000,000 310,000,000 335,000,000 386,000,000 326,000,000 384,000,000 295,000,000 365,000,000 289,000,000 266,000,000 234,000,000 315,000,000 278,000,000 339,000,000 -586,000,000 345,000,000 303,000,000 271,000,000 236,800,000 333,400,000 262,000,000 236,800,000 202,700,000 246,000,000 215,400,000 294,800,000 223,500,000 222,400,000 234,500,000 -38,200,000 273,200,000 312,900,000 316,500,000 249,100,000 318,000,000 356,000,000 324,700,000 301,800,000 902,200,000 19,000,000 739,300,000 270,700,000 321,000,000 146,800,000 304,000,000 228,300,000  
      yoy
    -25.20% 17.46% 8.87% 3.85% 96.14% 13.28% 6850.00% -454.55% -25.36% -372.31% -94.59% -148.18% -124.96% -365.31% -59.19% 19.13% -1258.33% -92.22%  -82.50% -65.81% 186.36%  236.92% 18.58% -21.71% -928.45% -116.72% 16.08% -73.31% 407.69% -519.42% -33.25% 225.00% -62.26% -17.01% -1.04% -0.61% -19.27% 13.56% 5.75% 12.80% 44.36% 26.07% 15.87% 3.96% -21.53% -139.93% -8.70% -8.25% 25.09% -347.47% 3.48% 15.65% 14.44% 16.82% 35.53% 21.63% -19.67% -9.31% 10.61% -8.14% -871.73% -18.19% -28.92% -25.91% -115.34% -14.09% -12.11% -2.53% -17.46% -64.75% 1773.68% -56.08% 11.49% 181.06% -87.06% 143.19% 18.57%      
      qoq
    -19.32% 3.74% 86.83% -52.17% 26.68% -3.84% 78.21% -9.65% -26.84% 5800.00% -109.09% -119.02% -366.92% -217.12% -18.98% -109.86% -2936.73% -81.99% 136.52% -4.17% -80.95%   87.18% 59.55% -104.47% -2623.59% -34.12% 5.34% -52.69% -150.94% -557.25% -75.78% 800.00% -57.91% -27.23% 17.90% 4.52% -7.46% -13.21% 18.40% -15.10% 30.17% -19.18% 26.30% 8.65% 13.68% -25.71% 13.31% -17.99% -157.85% -269.86% 13.86% 11.81% 14.44% -28.97% 27.25% 10.64% 16.82% -17.60% 14.21% -26.93% 31.90% 0.49% -5.16% -713.87% -113.98% -12.69% -1.14% 27.06% -21.67% -10.67% 9.64% 7.59% -66.55% 4648.42% -97.43% 173.11% -15.67% 118.66% -51.71% 33.16%   
      net income margin %
    0.62% 0.72% 0.71% 0.40% 0.93% 0.73% 0.80% 0.39% 0.47% 0.62% 0.01% -0.12% 0.69% -0.25% 0.22% 0.29% -3.10% 0.11% 0.62% 0.27% 0.31% 1.52% 0% 1.79% 0.90% 0.55% -13.18% 0.52% 0.84% 0.74% 1.69% -3.30% 0.76% 2.99% 0.36% 0.84% 1.20% 0.98% 0.97% 1.07% 1.26% 1.04% 1.37% 1.07% 1.44% 1.13% 1.11% 1.02% 1.47% 1.25% 1.38% -2.31% 1.41% 1.20% 1.05% 0.88% 1.24% 0.97% 0.88% 0.76% 0.94% 0.85% 1.21% 0.91% 0.91% 0.94% -0.15% 1.09% 1.25% 1.26% 1.02% 1.39% 1.55% 1.39% 1.37% 4.05% 0.09% 3.39% 1.27% 1.48% 0.71% 1.53% 1.18%  
      less: net (earnings)/loss attributable to noncontrolling interests
    19,000,000                                                                                    
      net earnings attributable to cardinal health, inc.
    399,000,000 467,000,000 450,000,000 239,000,000 506,000,000 400,000,000 416,000,000 236,000,000 258,000,000 353,000,000 5,000,000 -64,000,000 345,000,000 -130,000,000 110,000,000 138,000,000 -1,391,000,000 49,000,000 271,000,000 116,000,000 119,000,000 629,000,000  656,000,000 350,000,000 220,000,000 -4,922,000,000 194,000,000 296,000,000 280,000,000 593,000,000 -1,166,000,000 255,000,000 1,053,000,000 115,000,000 274,000,000 381,000,000 324,000,000 309,000,000 332,000,000 386,000,000 326,000,000 383,000,000                                          
      earnings per common share attributable to cardinal health, inc.:
                                                                                        
      basic
    1,690,000 1,980,000 1,890,000 1,010,000 2,110,000 1,650,000 1,710,000 970,000 1,060,000 1,440,000 20,000 -240,000 1,350,000 -500,000 410,000 470,000 -5,050,000 170,000 940,000 400,000 410,000 2,140,000  2,230,000 1,200,000 750,000 -16,650,000 660,000 990,000 940,000 1,950,000 -3,700,000 810,000 3,350,000 360,000 797,500 1,210,000 1,020,000 970,000 832,500 1,180,000 990,000 1,170,000                                          
      diluted
    1,690,000 1,970,000 1,880,000 1,010,000 2,100,000 1,650,000 1,700,000 960,000 1,050,000 1,430,000 20,000 -230,000 1,340,000 -500,000 400,000 470,000 -5,050,000 170,000 940,000 400,000 400,000 2,130,000  2,230,000 1,190,000 750,000 -16,650,000 650,000 990,000 930,000 1,940,000 -3,690,000 810,000 3,330,000 360,000 792,500 1,200,000 1,020,000 960,000 825,000 1,170,000 980,000 1,150,000                                          
      weighted-average number of common shares outstanding:
                                                                                        
      basic
    235,000,000 236,000,000 238,000,000 241,000,000 240,000,000 242,000,000 243,000,000 245,000,000 243,000,000 245,000,000 249,000,000 261,000,000 256,000,000 261,000,000 271,000,000 279,000,000 275,000,000 279,000,000 287,000,000 292,000,000 292,000,000 294,000,000 293,000,000 293,000,000 292,000,000 292,000,000 296,000,000 300,000,000 298,000,000 299,000,000 305,000,000 313,000,000 313,000,000 315,000,000 316,000,000 317,000,000 316,000,000 318,000,000 320,000,000 327,000,000 328,000,000 329,000,000 328,000,000 332,000,000 330,000,000 331,000,000 336,000,000 341,000,000 342,000,000 342,000,000 340,000,000 341,000,000 341,000,000 340,000,000 341,000,000 345,000,000 345,300,000 345,000,000 344,800,000 348,600,000 348,500,000 347,600,000 348,900,000 358,800,000 358,700,000 359,000,000 359,100,000 357,600,000 358,100,000 357,300,000 356,700,000 358,200,000 355,500,000 358,700,000 363,000,000 394,900,000 394,600,000 402,200,000 404,500,000 421,200,000 419,100,000 425,500,000 426,300,000  
      diluted
    236,000,000 237,000,000 239,000,000 242,000,000 241,000,000 243,000,000 245,000,000 247,000,000 245,000,000 246,000,000 250,000,000 262,000,000 258,000,000 261,000,000 273,000,000 279,000,000 275,000,000 281,000,000 289,000,000 294,000,000 294,000,000 295,000,000 293,000,000 293,000,000 294,000,000 294,000,000 296,000,000 301,000,000 299,000,000 300,000,000 306,000,000 315,000,000 315,000,000 316,000,000 318,000,000 320,000,000 318,000,000 319,000,000 322,000,000 330,000,000 331,000,000 332,000,000 331,000,000 335,000,000 334,000,000 334,000,000 340,000,000 345,000,000 347,000,000 346,000,000 344,000,000 344,000,000 345,000,000 343,000,000 344,000,000 349,000,000 349,500,000 348,800,000 349,400,000 352,500,000 352,900,000 350,700,000 351,900,000 361,400,000 361,800,000 361,000,000 359,100,000 361,500,000 360,900,000 360,300,000 361,100,000 364,000,000 360,200,000 364,600,000 370,200,000 404,700,000 394,600,000 410,600,000 413,000,000 428,500,000 427,500,000 431,900,000 431,400,000  
      cash dividends declared per common share
    510,700 510,700 510,700 379,200 505,600 505,600 505,600 375,450 500,600 500,600 500,600 371,775 495,700 495,700 495,700 368,100 490,800 490,800 490,800 364,425 485,900 485,900 485,900 360,825 481,100 481,100 481,100 357,225 476,300 476,300 476,300 346,800 462,400 462,400 462,400 336,675 448,900 448,900 448,900 290,250 387,000 387,000 387,000 256,875 342,500 342,500 342,500 226,875 302,500 302,500 302,500 196,875 275,000 275,000 237,500 161,250 215,000 215,000 215,000 146,250 195,000 195,000 195,000 131,250 175,000 175,000 175,000 105,000 140,000 140,000 140,000 90,000 120,000 120,000 120,000 67,500 90,000 90,000 90,000 45,000 60,000 60,000 60,000  
      less: net earnings attributable to noncontrolling interests
     -4,000,000 -4,000,000 -4,000,000 -2,000,000 -1,000,000 -1,000,000 2,000,000 -1,000,000 -1,000,000 -1,000,000 2,000,000 -2,000,000  -1,000,000 1,000,000 -1,000,000  -1,000,000 1,000,000 -1,000,000 -1,000,000  -1,000,000 -1,000,000  -1,000,000 -1,000,000  -1,000,000 -1,000,000    -2,000,000 -4,000,000 -1,000,000  -1,000,000 -3,000,000   -1,000,000                                          
      benefit from income taxes
              -32,000,000   -7,000,000    -1,022,000,000             142,000,000    61,000,000   167,000,000 184,000,000 241,000,000 226,000,000 194,000,000 184,000,000     128,000,000 192,000,000  102,000,000   180,000,000                               
      loss on early extinguishment of debt
                      10,000,000 13,000,000   1,000,000                                                              
      loss on sale of equity interest in navihealth
                    -1,000,000 -1,000,000                                                                   
      income before income taxes
                 -137,000,000         -663,000,000                                                              
      operating income
                          -624,000,000                                                              
      yoy
                                                                                        
      qoq
                                                                                        
      operating margin %
    0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% -1.60% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%  
      net income
                          -253,000,000                                                              
      net loss attributable to cardinal health, inc.
                          -253,000,000                                                              
      loss per common share attributable to cardinal health, inc.:
                                                                                        
      basic
                          -860,000                                                              
      diluted
                          -860,000                                                              
      loss on extinguishment of debt
                           2,250,000 5,000,000 4,000,000         1,000,000           60,000,000                     39,900,000                  
      impairments and (gain)/loss on disposal of assets
                               -123,000,000 11,000,000 8,000,000 -511,000,000 1,355,000,000 -6,000,000  1,000,000    3,000,000 4,000,000  17,000,000                                           
      other (income)/expense
                               3,250,000 -13,000,000 21,000,000 3,000,000 29,000,000 -2,000,000 -5,000,000 2,000,000   7,000,000 -3,000,000   -2,000,000 8,000,000           -4,000,000                               
      benefit from/(benefit from) income taxes
                               85,500,000 74,000,000 126,000,000  -21,000,000 209,000,000 -736,000,000                                                   
      distribution, selling, general, and administrative expenses
                                         910,000,000 920,000,000 970,000,000 914,000,000 922,000,000 842,000,000                                          
      other income
                                               -1,000,000 -2,000,000 -1,000,000 -3,000,000 -3,000,000 -33,000,000 -6,000,000 -4,000,000 2,000,000 -6,000,000   2,000,000 -7,700,000   -4,850,000 -6,200,000 -5,800,000 -7,500,000                      
      earnings before income taxes and discontinued operations
                                               523,000,000 558,000,000 451,000,000 435,000,000 357,000,000 507,000,000 492,000,000 442,000,000 -481,000,000 447,000,000 483,000,000 439,000,000 377,000,000 510,400,000 425,600,000 385,000,000 341,300,000 425,100,000 327,800,000 424,200,000 308,400,000 363,200,000 365,000,000 175,000,000 391,800,000 435,900,000 475,500,000 363,900,000 488,300,000 545,400,000 469,200,000 446,900,000 401,400,000 -42,000,000 479,700,000 416,000,000 333,500,000 525,000,000 450,500,000 340,700,000  
      earnings from continuing operations
                                               292,000,000 365,000,000 289,000,000 266,000,000 234,000,000 315,000,000 275,000,000 340,000,000 -586,000,000 346,000,000 303,000,000 272,000,000 236,100,000 332,500,000 264,400,000 237,100,000 207,400,000 249,500,000 215,000,000 294,400,000 193,800,000 224,800,000 230,200,000 -61,800,000 260,700,000 313,500,000 318,900,000 249,800,000 321,600,000 365,900,000 325,100,000 303,200,000 237,700,000 -4,900,000 315,700,000 300,300,000 226,475,000 355,800,000 304,000,000 234,600,000  
      earnings from discontinued operations, net of tax
                                                     3,000,000  -250,000 -1,000,000   700,000 900,000 -2,400,000 -300,000 -4,700,000 -3,500,000 400,000 400,000 29,700,000 -2,400,000                    
      basic earnings per common share:
                                                                                        
      continuing operations
                                               880,000 1,100,000 870,000 790,000 690,000 920,000 800,000 1,000,000 -1,720,000 1,010,000 890,000 800,000 680,000 960,000 770,000 690,000 590,000 720,000 620,000 840,000 540,000 630,000 640,000 -170,000 730,000 880,000 890,000 700,000 900,000 1,030,000 910,000 830,000 630,000 -10,000 780,000 740,000 820,000 850,000 710,000 550,000  
      discontinued operations
                                                     10,000      -2,500  -10,000  -10,000 -10,000   80,000 -10,000 10,000 60,000 30,000    -10,000 -30,000   1,690,000 60,000 1,060,000 -70,000 -40,000 -500,000  -10,000  
      net basic earnings per common share
                                               890,000 1,100,000 870,000 790,000 690,000 920,000 810,000 1,000,000 -1,720,000 1,010,000 890,000 800,000 690,000 960,000 760,000 690,000 580,000 710,000 620,000 840,000 620,000 620,000 650,000 -110,000 760,000 880,000 890,000 700,000 890,000 1,000,000 910,000 830,000 2,320,000 50,000 1,840,000 670,000 780,000 350,000 710,000 540,000  
      diluted earnings per common share:
                                                                                        
      net diluted earnings per common share
                                               880,000 1,090,000 860,000 780,000 680,000 910,000 800,000 990,000 -1,700,000 1,000,000 880,000 790,000 680,000 950,000 750,000 680,000 570,000 700,000 610,000 840,000 610,000 610,000 650,000 -110,000 750,000 870,000 880,000 690,000 880,000 990,000 890,000 820,000 2,260,000 50,000 1,800,000 660,000 750,000 340,000 700,000 530,000  
      loss from discontinued operations, net of tax
                                                          -1,000,000                              
      earnings/(loss) from discontinued operations, net of tax
                                                   750,000                                     
      diluted earnings/(loss) per common share:
                                                                                        
      income from discontinued operations, net of tax
                                                      -1,000,000                                  
      acquisition-related costs
                                                       52,000,000 53,000,000 25,000,000 28,000,000 10,200,000 -26,600,000 21,900,000 27,400,000                          
      basic earnings/(loss) per common share:
                                                                                        
      distribution, selling, general and administrative expense
                                                           491,400,000 682,700,000 639,800,000  477,775,000 697,300,000 621,900,000                       
      loss on sale of investment in carefusion
                                                               -17,875,000 3,300,000                        
      impairments and loss on sale of assets
                                                             1,100,000 1,300,000 400,000 4,600,000 1,700,000 1,900,000 900,000 4,200,000 400,000 23,600,000                  
      gain on sale of investment in carefusion
                                                                  -74,800,000                      
      acquisition related costs
                                                               5,450,000 2,500,000 18,000,000 1,300,000                      
      litigation (credits)/charges
                                                               2,975,000 4,300,000 6,100,000 1,400,000 -33,600,000 -2,900,000 -25,400,000 -500,000                  
      operating expenses
                                                                                        
      gain on sale of carefusion common stock
                                                                   -1,300,000 -23,200,000                    
      earnings from discontinued operations
                                                                     4,300,000 23,600,000     -3,600,000 -9,900,000 -400,000  664,500,000 23,900,000 423,600,000       
      selling, general and administrative expenses
                                                                       854,100,000 850,200,000 851,900,000 882,200,000 901,300,000 854,500,000 828,900,000 830,100,000 819,300,000 781,700,000 755,600,000 807,300,000 853,900,000 778,600,000 796,700,000 815,600,000  
      impairments, loss on sale of assets and other
                                                                       11,500,000 3,000,000 6,900,000 3,600,000              
      special items – restructuring charges
                                                                       28,025,000 48,100,000 14,200,000    31,500,000 14,800,000 7,100,000 6,600,000 10,000,000 13,400,000 9,825,000 20,600,000 14,400,000 9,100,000  
      – acquisition integration charges
                                                                       2,950,000 3,500,000 5,800,000    10,000,000 5,400,000          
      – litigation and other
                                                                       125,000 600,000 -300,000    -12,000,000 2,300,000 152,850,000 602,500,000        
      interest expense and other
                                                                       33,400,000 60,400,000 62,400,000 62,400,000 47,400,000 31,100,000 50,000,000 42,900,000 19,200,000 32,200,000 32,400,000 47,700,000 33,300,000 34,400,000 33,900,000 31,700,000  
      losses from discontinued operations
                                                                       -925,000 -600,000                
      loss from discontinued operations
                                                                         -2,400,000 -700,000    -1,400,000    -29,600,000 -17,800,000 -209,000,000  -6,300,000  
      special items
                                                                          49,700,000 13,675,000 8,500,000            
      impairment charges and other
                                                                           -5,500,000 1,200,000 -23,000,000 -200,000 -600,000 3,600,000 12,600,000 3,600,000 4,400,000 8,200,000 5,100,000 2,500,000  
      – merger-related costs
                                                                               3,500,000 2,900,000        
      – merger charges
                                                                                 9,100,000  5,200,000 7,500,000 7,500,000 7,800,000  
      – other
                                                                                 500,000 8,400,000 -50,000 -5,100,000 -900,000 5,800,000  
      – merger related charges
                                                                                  2,500,000      
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 
                                                                                          
        assets
                                                                                          
        current assets:
                                                                                          
        cash and equivalents
      3,937,000,000 2,777,000,000 4,593,000,000 3,874,000,000 3,326,000,000 3,810,000,000 2,867,000,000 5,133,000,000 3,718,000,000 4,591,000,000 3,854,000,000 4,043,000,000 3,990,000,000 3,654,000,000 3,492,000,000 4,717,000,000 2,356,000,000 3,161,000,000 2,463,000,000 3,407,000,000 3,499,000,000 3,737,000,000 2,746,000,000 2,771,000,000 2,329,000,000 1,659,000,000 1,212,000,000 2,531,000,000 3,438,000,000 2,182,000,000 2,045,000,000 1,763,000,000 2,175,000,000 1,249,000,000 1,181,000,000 6,879,000,000 1,368,000,000 1,881,000,000 2,001,000,000 2,356,000,000 2,598,000,000 2,324,000,000 2,974,000,000 4,616,000,000 3,183,000,000 2,881,000,000 2,469,000,000 2,865,000,000 3,041,000,000 2,741,000,000 2,753,000,000 1,901,000,000 2,305,000,000 2,255,000,000 2,440,000,000 2,274,000,000 2,410,400,000 1,797,700,000 2,010,600,000 1,929,300,000 1,961,800,000 1,348,000,000 2,712,200,000 2,755,300,000 2,638,800,000 1,746,800,000 1,584,800,000 1,847,500,000 1,366,000,000 772,600,000 672,200,000 1,291,300,000 1,529,000,000 1,184,400,000 1,289,600,000 1,308,800,000  1,003,300,000 1,609,600,000 1,320,900,000 1,713,400,000 2,223,900,000 1,976,900,000 1,411,700,000 
        trade receivables
      13,648,000,000 13,662,000,000 13,770,000,000 13,242,000,000 12,666,000,000 12,369,000,000 11,781,000,000 12,084,000,000 11,566,000,000 11,788,000,000 11,265,000,000 11,344,000,000 10,992,000,000 11,421,000,000 11,039,000,000 10,561,000,000 10,250,000,000 9,406,000,000 9,305,000,000 9,103,000,000 8,727,000,000 8,728,000,000 8,637,000,000 8,264,000,000 9,019,000,000 8,280,000,000 8,190,000,000 8,448,000,000 7,879,000,000 7,932,000,000 8,082,000,000 7,800,000,000 7,671,000,000 7,664,000,000 8,382,000,000 8,048,000,000 7,505,000,000 7,533,000,000 7,708,000,000 7,405,000,000 7,292,000,000 6,980,000,000 6,996,000,000 6,523,000,000 6,095,000,000 5,653,000,000 5,662,000,000 5,380,000,000 4,812,000,000 4,876,000,000 4,898,000,000 6,304,000,000 6,416,000,000 6,158,000,000 6,449,000,000 6,355,000,000 6,495,400,000 5,995,400,000 6,232,600,000 6,155,700,000 6,282,500,000 5,825,300,000 5,454,100,000 5,170,600,000 5,550,200,000 4,927,500,000 5,921,900,000 5,643,600,000 5,904,700,000 5,215,300,000 5,862,300,000 5,006,900,000 4,974,300,000 4,854,600,000 4,904,700,000 4,714,400,000 4,618,500,000 4,394,500,000 3,986,600,000 4,111,600,000 3,937,500,000 3,543,800,000 3,712,400,000 3,451,000,000 
        inventories
      18,007,000,000 20,116,000,000 17,559,000,000 16,831,000,000 16,158,000,000 16,904,000,000 15,619,000,000 14,957,000,000 17,277,000,000 18,451,000,000 16,987,000,000 15,940,000,000 16,620,000,000 17,263,000,000 15,891,000,000 15,636,000,000 15,493,000,000 14,941,000,000 14,720,000,000 14,594,000,000 14,329,000,000 14,443,000,000 13,439,000,000 13,198,000,000 12,808,000,000 13,799,000,000 12,458,000,000 12,822,000,000 12,622,000,000 13,037,000,000 12,481,000,000 12,308,000,000 11,962,000,000 12,087,000,000 12,121,000,000 11,301,000,000 11,641,000,000 11,915,000,000 10,917,000,000 10,615,000,000 10,910,000,000 11,007,000,000 9,758,000,000 9,211,000,000 9,163,000,000 9,408,000,000 8,069,000,000 8,266,000,000 8,030,000,000 8,478,000,000 7,275,000,000 8,373,000,000 8,328,000,000 8,452,000,000 8,105,000,000 7,864,000,000 8,220,100,000 8,888,900,000 7,497,200,000 7,334,200,000 7,717,700,000 8,314,200,000 7,087,500,000 6,355,900,000 7,214,900,000 7,961,000,000 6,861,900,000 7,145,500,000 8,070,300,000 8,535,800,000 7,692,100,000 6,768,800,000 7,256,700,000 7,636,800,000 7,150,800,000 7,383,200,000 7,486,500,000 7,309,200,000 7,585,300,000 7,714,200,000 7,651,200,000 7,276,700,000 7,376,000,000 7,380,000,000 
        prepaid expenses and other
      2,472,000,000 2,675,000,000 2,602,000,000 2,414,000,000 2,398,000,000 2,623,000,000 2,591,000,000 2,663,000,000 3,161,000,000 2,816,000,000 2,582,000,000 2,362,000,000 1,895,000,000 2,258,000,000 2,274,000,000 2,021,000,000 2,785,000,000 4,339,000,000 3,243,000,000 2,843,000,000 2,715,000,000 3,205,000,000 2,208,000,000 1,707,000,000 1,692,000,000 1,998,000,000 1,855,000,000 1,946,000,000 1,643,000,000 1,940,000,000 1,837,000,000 1,926,000,000 1,705,000,000 1,972,000,000 2,041,000,000 2,117,000,000 1,769,000,000 1,824,000,000 1,657,000,000 1,580,000,000 1,491,000,000 1,518,000,000 1,490,000,000 1,402,000,000 1,190,000,000 1,213,000,000 1,338,000,000 1,428,000,000 1,053,000,000 1,153,000,000 1,111,000,000 1,192,000,000 878,000,000 996,000,000 1,013,000,000 1,017,000,000 944,300,000 1,097,100,000 982,800,000 896,700,000 723,400,000 789,500,000 664,400,000 637,100,000 534,500,000 674,100,000 557,800,000 588,800,000 561,200,000 624,100,000 614,900,000 593,100,000 578,000,000 667,700,000 619,000,000 651,300,000 535,700,000 579,800,000 710,500,000 628,900,000 863,100,000 862,100,000 773,900,000 862,000,000 
        assets held for sale
        13,000,000 12,000,000 47,000,000 50,000,000 47,000,000 47,000,000 12,000,000 12,000,000  144,000,000        1,101,000,000 1,092,000,000           756,000,000  2,216,000,000                                      140,400,000 187,900,000            
        total current assets
      38,064,000,000 39,230,000,000 38,537,000,000 36,373,000,000 34,595,000,000 35,756,000,000 32,905,000,000 34,884,000,000 35,734,000,000 37,658,000,000 34,688,000,000 33,833,000,000 33,497,000,000 34,596,000,000 32,696,000,000 32,935,000,000 30,884,000,000 31,847,000,000 29,731,000,000 31,048,000,000 30,362,000,000 30,113,000,000 27,030,000,000 25,940,000,000 25,848,000,000 25,736,000,000 23,715,000,000 25,747,000,000 25,582,000,000 25,091,000,000 24,445,000,000 24,553,000,000 23,513,000,000 25,188,000,000 23,725,000,000 28,345,000,000 22,283,000,000 23,153,000,000 22,283,000,000 21,956,000,000 22,291,000,000 21,829,000,000 21,218,000,000 21,752,000,000 19,631,000,000 19,155,000,000 17,538,000,000 17,939,000,000 16,936,000,000 17,248,000,000 16,037,000,000 17,770,000,000 17,927,000,000 17,861,000,000 18,007,000,000 17,510,000,000 18,070,200,000 17,779,100,000 16,723,200,000 16,315,900,000 16,685,400,000 16,277,000,000 15,918,200,000 14,918,900,000 16,077,300,000 15,458,300,000 15,089,000,000 15,799,000,000 16,304,900,000 15,536,600,000 15,226,300,000 14,184,200,000 14,907,100,000 14,721,800,000 14,333,200,000 14,544,500,000 17,262,400,000 17,178,100,000 14,721,200,000 14,776,700,000 15,254,100,000 14,612,600,000 14,325,900,000 13,442,700,000 
        property and equipment
      2,928,000,000 2,877,000,000 2,831,000,000 2,858,000,000 2,664,000,000 2,558,000,000 2,535,000,000 2,529,000,000 2,470,000,000 2,446,000,000 2,441,000,000 2,462,000,000 2,362,000,000 2,341,000,000 2,339,000,000 2,361,000,000 2,298,000,000 2,321,000,000 2,336,000,000 2,360,000,000 2,315,000,000 2,386,000,000 2,369,000,000 2,366,000,000 2,299,000,000 2,301,000,000 2,324,000,000 2,356,000,000 2,322,000,000 2,376,000,000 2,436,000,000 2,487,000,000 2,521,000,000 2,547,000,000 2,651,000,000 1,879,000,000 1,849,000,000 1,856,000,000 1,823,000,000 1,796,000,000 1,683,000,000 1,651,000,000 1,546,000,000 1,506,000,000 1,407,000,000 1,415,000,000 1,434,000,000 1,459,000,000 1,404,000,000 1,407,000,000 1,445,000,000 1,489,000,000 1,470,000,000 1,475,000,000 1,511,000,000 1,551,000,000 1,517,400,000 1,514,100,000 1,494,000,000 1,512,200,000 1,469,800,000 1,484,800,000 1,475,300,000 1,468,800,000 1,406,100,000 1,423,200,000 1,438,600,000 1,873,000,000 1,724,000,000 1,729,600,000 1,749,500,000 1,737,200,000 1,679,500,000 1,680,700,000 1,683,100,000 1,647,000,000 1,533,700,000 1,518,500,000 2,574,100,000 2,584,000,000 2,489,100,000 2,490,000,000 2,449,600,000 2,484,000,000 
        goodwill and other intangibles
      13,698,000,000 13,978,000,000 12,110,000,000 12,177,000,000 11,014,000,000 7,436,000,000 6,388,000,000 6,450,000,000 6,507,000,000 5,371,000,000 5,432,000,000 6,081,000,000 6,567,000,000 6,618,000,000 7,367,000,000 7,629,000,000 8,022,000,000 8,599,000,000 10,005,000,000 10,094,000,000 10,179,000,000 11,102,000,000 11,186,000,000 11,275,000,000 11,378,000,000 11,523,000,000 11,658,000,000 11,808,000,000 11,860,000,000 11,973,000,000 12,093,000,000 12,229,000,000 14,299,000,000 14,366,000,000 14,926,000,000 9,207,000,000 9,287,000,000 9,276,000,000 9,427,000,000 9,426,000,000 9,150,000,000 9,113,000,000 7,564,000,000 6,018,000,000 6,033,000,000 5,876,000,000 5,923,000,000 5,870,000,000 5,593,000,000 5,556,000,000 5,570,000,000 5,574,000,000 6,413,000,000 4,428,000,000 4,441,000,000 4,392,000,000 4,370,800,000 4,244,300,000 4,249,300,000 4,259,000,000 4,265,700,000 4,282,600,000 2,896,900,000 2,253,200,000 2,261,800,000 2,294,700,000 2,269,300,000 6,095,900,000 6,141,500,000 6,183,000,000 6,265,100,000 6,225,900,000 5,681,000,000 5,813,100,000 5,822,800,000 5,860,900,000 4,406,900,000 4,391,300,000 5,054,500,000 4,992,400,000 4,822,100,000 5,082,600,000 5,068,100,000 5,097,400,000 
        other assets
      1,999,000,000 1,998,000,000 1,750,000,000 1,714,000,000 1,598,000,000 1,252,000,000 1,231,000,000 1,258,000,000 1,169,000,000 1,098,000,000 1,149,000,000 1,041,000,000 951,000,000 927,000,000 985,000,000 953,000,000 907,000,000 913,000,000 921,000,000 951,000,000 1,018,000,000 1,118,000,000 1,142,000,000 1,185,000,000 1,623,000,000 1,482,000,000 1,482,000,000 1,052,000,000 1,045,000,000 1,022,000,000 643,000,000 682,000,000 698,000,000 804,000,000 638,000,000 681,000,000 755,000,000 736,000,000 873,000,000 944,000,000 931,000,000 914,000,000 894,000,000 866,000,000 817,000,000 802,000,000 816,000,000 765,000,000 768,000,000 798,000,000 764,000,000 986,000,000 913,000,000 878,000,000 861,000,000                              
        total assets
      56,689,000,000 58,083,000,000 55,228,000,000 53,122,000,000 49,871,000,000 47,002,000,000 43,059,000,000 45,121,000,000 45,880,000,000 46,573,000,000 43,710,000,000 43,417,000,000 43,377,000,000 44,482,000,000 43,387,000,000 43,878,000,000 42,111,000,000 43,680,000,000 42,993,000,000 44,453,000,000 43,874,000,000 44,719,000,000 41,727,000,000 40,766,000,000 41,148,000,000 41,042,000,000 39,179,000,000 40,963,000,000 40,809,000,000 40,462,000,000 40,011,000,000 39,951,000,000 41,031,000,000 42,905,000,000 41,940,000,000 40,112,000,000 34,174,000,000 35,021,000,000 34,406,000,000 34,122,000,000 34,055,000,000 33,507,000,000 31,222,000,000 30,142,000,000 27,888,000,000 27,248,000,000 25,711,000,000 26,033,000,000 24,701,000,000 25,009,000,000 23,816,000,000 25,819,000,000 26,723,000,000 24,642,000,000 24,820,000,000 24,260,000,000 24,642,100,000 24,263,200,000 23,183,000,000 22,845,900,000 23,196,800,000 22,849,700,000 20,972,500,000 19,990,200,000 21,270,200,000 20,821,500,000 20,434,700,000 25,118,800,000 25,534,800,000 25,014,800,000 24,645,100,000 23,448,200,000 23,603,400,000 23,466,800,000 22,998,100,000 23,153,800,000 24,292,000,000 24,137,200,000 23,431,200,000 23,374,100,000 23,645,600,000 23,230,200,000 22,969,900,000 22,059,200,000 
        liabilities and shareholders’ deficit
                                                                                          
        current liabilities:
                                                                                          
        accounts payable
      37,834,000,000 38,996,000,000 36,860,000,000 34,713,000,000 32,812,000,000 31,298,000,000 30,365,000,000 31,759,000,000 32,089,000,000 34,259,000,000 31,540,000,000 29,813,000,000 29,601,000,000 30,083,000,000 28,362,000,000 27,128,000,000 24,821,000,000 24,759,000,000 23,408,000,000 23,700,000,000 22,641,000,000 23,235,000,000 21,688,000,000 21,374,000,000 21,984,000,000 21,459,000,000 19,724,000,000 21,535,000,000 20,517,000,000 20,610,000,000 20,236,000,000 19,677,000,000 18,741,000,000 19,194,000,000 19,202,000,000 17,906,000,000 17,535,000,000 18,857,000,000 17,597,000,000 17,306,000,000 17,340,000,000 16,919,000,000 14,868,000,000 14,368,000,000 13,851,000,000 13,602,000,000 11,995,000,000 12,149,000,000 10,919,000,000 11,221,000,000 10,442,000,000 12,295,000,000 12,049,000,000 11,796,000,000 12,215,000,000 11,726,000,000 12,572,500,000 12,456,700,000 11,748,900,000 11,331,500,000 11,961,500,000 11,778,800,000 10,532,300,000 9,494,900,000 10,766,600,000 10,543,100,000 10,047,100,000 9,138,000,000 10,006,200,000 9,666,200,000 9,354,600,000 8,311,800,000 8,987,900,000 8,982,300,000 9,099,000,000 9,162,200,000 9,405,700,000 8,984,700,000 8,878,300,000 9,009,300,000 8,826,400,000 8,116,600,000 8,082,800,000 7,618,400,000 
        current portion of long-term obligations and other short-term borrowings
      671,000,000 680,000,000 52,000,000 550,000,000 543,000,000 544,000,000 940,000,000 434,000,000 1,187,000,000 1,188,000,000 788,000,000 792,000,000 26,000,000 577,000,000 578,000,000 580,000,000 861,000,000 301,000,000 301,000,000 871,000,000 16,000,000 13,000,000 12,000,000 10,000,000 508,000,000 1,192,000,000 631,000,000 452,000,000 1,451,000,000 1,450,000,000 1,002,000,000 1,001,000,000 551,000,000 702,000,000 935,000,000 1,327,000,000 607,000,000 603,000,000 616,000,000 587,000,000 351,000,000 354,000,000 319,000,000 281,000,000 283,000,000 270,000,000 843,000,000 801,000,000 241,000,000 255,000,000 190,000,000 168,000,000 446,000,000 474,000,000 471,000,000 476,000,000 345,500,000 341,800,000 333,100,000 326,700,000 113,700,000 289,900,000 233,600,000 233,200,000 232,600,000 12,700,000 362,300,000 367,300,000 368,000,000 467,400,000 166,500,000 159,000,000 355,300,000 673,600,000 386,800,000 16,000,000 296,900,000 48,900,000 315,300,000 229,200,000 280,700,000 441,300,000 405,300,000 307,900,000 
        other accrued liabilities
      3,484,000,000 3,638,000,000 3,356,000,000 3,634,000,000 3,307,000,000 3,381,000,000 3,373,000,000 3,447,000,000 3,030,000,000 2,839,000,000 2,737,000,000 3,059,000,000 2,876,000,000 2,552,000,000 2,619,000,000 2,842,000,000 3,033,000,000 2,669,000,000 2,790,000,000 2,957,000,000 2,573,000,000 2,502,000,000 2,316,000,000 2,231,000,000 2,179,000,000 2,239,000,000 2,194,000,000 2,122,000,000 1,951,000,000 1,764,000,000 1,819,000,000 2,002,000,000 2,135,000,000 1,890,000,000 2,270,000,000 1,988,000,000 1,654,000,000 1,554,000,000 1,788,000,000 1,808,000,000 1,694,000,000 1,606,000,000 2,595,000,000 2,594,000,000 2,261,000,000 2,158,000,000 2,058,000,000 2,165,000,000 1,987,000,000 1,886,000,000 1,875,000,000 2,127,000,000 1,979,000,000 1,932,000,000 1,983,000,000 1,972,000,000 1,928,100,000 1,825,200,000 1,714,600,000 1,711,300,000 1,685,900,000 1,562,400,000 1,685,700,000 1,809,500,000 1,712,900,000 1,609,900,000 1,701,700,000 1,868,200,000  1,503,000,000 1,902,600,000 1,889,700,000 1,778,200,000 1,751,000,000 1,623,000,000 2,247,300,000 2,724,500,000 2,139,600,000 2,373,800,000 2,053,900,000 2,209,500,000 2,324,000,000 2,250,300,000 2,178,700,000 
        total current liabilities
      41,989,000,000 43,314,000,000 40,268,000,000 38,897,000,000 36,662,000,000 35,223,000,000 34,678,000,000 35,640,000,000 36,306,000,000 38,286,000,000 35,065,000,000 33,706,000,000 32,503,000,000 33,212,000,000 31,559,000,000 30,550,000,000 28,715,000,000 27,729,000,000 26,499,000,000 27,624,000,000 25,323,000,000 25,750,000,000 24,016,000,000 23,615,000,000 24,671,000,000 24,890,000,000 22,549,000,000 24,109,000,000 23,919,000,000 23,824,000,000 23,057,000,000 22,893,000,000 21,427,000,000 23,125,000,000 22,407,000,000 21,221,000,000 19,796,000,000 21,014,000,000 20,001,000,000 19,701,000,000 19,385,000,000 18,879,000,000 17,782,000,000 17,243,000,000 16,395,000,000 16,030,000,000 14,896,000,000 15,115,000,000 13,147,000,000 13,362,000,000 12,507,000,000 14,590,000,000 14,474,000,000 14,202,000,000 14,669,000,000 14,174,000,000 14,846,100,000 14,623,700,000 13,796,600,000 13,369,500,000 13,761,100,000 13,631,100,000 12,451,600,000 11,537,600,000 12,747,400,000 12,203,000,000 12,146,700,000 11,399,800,000 11,926,500,000 11,639,000,000 11,426,100,000 10,375,900,000 11,142,000,000 11,410,500,000 11,114,000,000 11,459,700,000 12,945,400,000 11,702,600,000 11,578,300,000 11,372,800,000 11,471,800,000 10,890,700,000 10,747,800,000 10,105,000,000 
        long-term obligations, less current portion
      8,245,000,000 8,347,000,000 8,980,000,000 7,977,000,000 7,136,000,000 7,062,000,000 4,224,000,000 4,658,000,000 4,667,000,000 3,535,000,000 3,890,000,000 3,909,000,000 4,708,000,000 4,685,000,000 4,689,000,000 4,735,000,000 4,751,000,000 5,342,000,000 5,353,000,000 5,365,000,000 6,715,000,000 6,720,000,000 6,728,000,000 6,765,000,000 6,754,000,000 6,742,000,000 7,360,000,000 7,579,000,000 7,629,000,000 7,599,000,000 7,999,000,000 8,012,000,000 9,027,000,000 9,057,000,000 9,068,000,000 9,068,000,000 4,854,000,000 4,859,000,000 4,916,000,000 4,952,000,000 5,195,000,000 5,171,000,000 5,231,000,000 5,211,000,000 3,720,000,000 3,706,000,000 3,164,000,000 3,171,000,000 3,679,000,000 3,679,000,000 3,693,000,000 3,686,000,000 3,714,000,000 2,423,000,000 2,408,000,000 2,418,000,000 2,207,900,000 2,211,400,000 2,195,000,000 2,175,300,000 2,362,100,000 2,380,200,000 1,906,400,000 1,896,100,000       3,597,000,000              
        deferred income taxes and other liabilities
      9,127,000,000 9,122,000,000 8,711,000,000 8,882,000,000 7,971,000,000 7,638,000,000 7,433,000,000 8,035,000,000 8,169,000,000 8,199,000,000 8,245,000,000 8,653,000,000 8,384,000,000 8,797,000,000 8,919,000,000 9,299,000,000 9,338,000,000 9,607,000,000 9,745,000,000 9,670,000,000 10,042,000,000 10,274,000,000 9,558,000,000 8,594,000,000 8,517,000,000 8,408,000,000 8,367,000,000 2,945,000,000 3,029,000,000 2,996,000,000 3,042,000,000 2,975,000,000 3,027,000,000 3,091,000,000 3,758,000,000 2,877,000,000 2,742,000,000 2,692,000,000 2,842,000,000 2,781,000,000 2,628,000,000 2,609,000,000 1,563,000,000 1,432,000,000 1,404,000,000 1,412,000,000 1,395,000,000 1,346,000,000 1,343,000,000 1,379,000,000 1,319,000,000 1,568,000,000 1,705,000,000 1,475,000,000 1,462,000,000 1,424,000,000 1,348,000,000 1,500,400,000 1,477,500,000 1,452,500,000 1,416,800,000 1,417,000,000 1,375,500,000 1,280,400,000 1,286,300,000 1,293,200,000 1,243,300,000 1,714,300,000 1,870,700,000 1,858,700,000 1,703,900,000 1,637,400,000 1,618,100,000 1,551,700,000 1,468,400,000 859,900,000 578,200,000 591,000,000 804,400,000 910,900,000 1,038,800,000 1,020,200,000 1,139,200,000 1,041,300,000 
        shareholders’ deficit:
                                                                                          
        preferred shares, without par value:
                                                                                          
        authorized—500 thousand shares, issued—none
                                                                                          
        common shares, without par value:
                                                                                          
        authorized—755 million shares, issued—271 million shares at march 31, 2026 and june 30, 2025
      2,815,000,000                                                                                    
        retained earnings
      1,732,000,000 1,455,000,000 1,116,000,000               1,245,000,000 1,335,000,000 1,205,000,000 1,233,000,000 1,255,000,000 771,000,000 1,170,000,000 656,000,000 449,000,000 371,000,000 5,434,000,000 5,386,000,000 5,233,000,000 5,097,000,000 4,645,000,000 5,958,000,000 5,848,000,000 4,943,000,000 4,967,000,000 4,842,000,000 4,604,000,000 6,582,000,000 6,419,000,000 6,231,000,000 5,972,000,000 5,774,000,000 5,521,000,000 5,353,000,000 5,100,000,000 4,925,000,000 4,774,000,000 4,657,000,000 4,446,000,000 4,273,000,000 4,038,000,000 4,742,000,000 4,491,000,000 4,282,000,000 4,093,000,000 3,938,800,000 3,679,800,000 3,492,600,000 3,331,400,000 3,189,800,000 3,023,700,000 2,876,000,000 2,647,200,000 2,463,900,000 2,306,500,000 2,124,100,000 5,953,900,000 5,743,700,000 5,481,400,000 5,215,200,000 5,016,200,000 4,748,200,000 4,436,500,000 11,658,600,000 11,539,900,000 10,681,300,000 10,692,500,000 9,994,500,000 9,760,500,000 9,477,400,000 9,354,300,000 9,078,300,000 8,874,200,000 
        common shares in treasury, at cost: 36 million shares and 32 million shares at march 31, 2026 and june 30, 2025, respectively
      -7,218,000,000                                                                                    
        accumulated other comprehensive loss
      -161,000,000 -153,000,000 -159,000,000 -155,000,000 -176,000,000 -180,000,000 -155,000,000 -167,000,000 -160,000,000 -155,000,000 -165,000,000 -151,000,000 -142,000,000 -146,000,000 -176,000,000 -114,000,000 -77,000,000 -85,000,000 -61,000,000 -34,000,000 -48,000,000 -53,000,000 -87,000,000 -104,000,000 -141,000,000 -103,000,000 -101,000,000 -79,000,000 -111,000,000 -123,000,000 -96,000,000 -92,000,000 -5,000,000 -95,000,000 -86,000,000 -125,000,000 -136,000,000 -170,000,000 -116,000,000 -116,000,000 -84,000,000 -97,000,000 -68,000,000                                          
        total cardinal health, inc. shareholders' deficit
      -2,832,000,000 -2,884,000,000 -2,879,000,000 -2,781,000,000 -2,948,000,000 -2,991,000,000 -3,277,000,000 -3,213,000,000 -3,265,000,000 -3,449,000,000 -3,491,000,000 -2,852,000,000 -2,220,000,000 -2,213,000,000 -1,781,000,000                                                                      
        noncontrolling interests
      160,000,000 184,000,000 148,000,000 147,000,000 1,050,000,000 70,000,000 1,000,000 1,000,000 3,000,000 2,000,000 1,000,000 1,000,000 2,000,000 1,000,000 1,000,000 3,000,000 4,000,000 4,000,000 3,000,000 3,000,000 4,000,000 4,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 2,000,000 2,000,000    1,000,000 20,000,000 17,000,000 20,000,000 19,000,000 18,000,000 19,000,000 17,000,000 17,000,000 17,000,000 22,000,000                                          
        total shareholders’ deficit
      -2,672,000,000 -2,700,000,000 -2,731,000,000 -2,634,000,000 -1,898,000,000 -2,921,000,000 -3,276,000,000 -3,212,000,000 -3,262,000,000 -3,447,000,000 -3,490,000,000 -2,851,000,000 -2,218,000,000 -2,212,000,000 -1,780,000,000                                                                      
        total liabilities and shareholders’ deficit
      56,689,000,000 58,083,000,000 55,228,000,000 53,122,000,000 49,871,000,000 47,002,000,000 43,059,000,000 45,121,000,000 45,880,000,000 46,573,000,000 43,710,000,000 43,417,000,000 43,377,000,000 44,482,000,000 43,387,000,000                                                                      
        authorized—755 million shares, issued—271 million shares at december 31, 2025 and june 30, 2025
       2,847,000,000                                                                                   
        common shares in treasury, at cost: 35 million shares and 32 million shares at december 31, 2025 and june 30, 2025, respectively
       -7,033,000,000                                                                                   
        authorized—755 million shares, issued—271 million shares at september 30, 2025 and june 30,2025
        2,746,000,000                                                                                  
        common shares in treasury, at cost: 33 million shares and 32 million shares at september 30, 2025 and june 30, 2025, respectively
        -6,582,000,000                                                                                  
        authorized—755 million shares, issued— 271 million shares 327 million shares at june 30, 2025 and 2024, respectively
         2,956,000,000                                                                                 
        retained earnings/
         783,000,000 664,000,000 283,000,000 14,000,000         -280,000,000 -281,000,000                                                                    
        common shares in treasury, at cost: 32 million shares and 83 million shares at june 30, 2025 and 2024, respectively
         -6,365,000,000                                                                                 
        authorized—755 million shares, issued—271 million shares and 327 million shares at march 31, 2025 and june 30, 2024, respectively
          2,946,000,000                                                                                
        common shares in treasury, at cost: 32 million shares and 83 million shares at march 31, 2025 and june 30, 2024, respectively
          -6,382,000,000                                                                                
        authorized—755 million shares, issued—271 million shares and 327 million shares at december 31, 2024 and june 30, 2024, respectively
           2,932,000,000                                                                               
        common shares in treasury, at cost: 29 million shares and 83 million shares at december 31, 2024 and june 30, 2024, respectively
           -6,026,000,000                                                                               
        authorized—755 million shares, issued—327 million shares at september 30, 2024 and june 30,2024
            2,827,000,000                                                                              
        common shares in treasury, at cost: 85 million shares and 83 million shares at september 30, 2024 and june 30, 2024, respectively
            -5,963,000,000                                                                              
        liabilities related to assets held for sale
                 42,000,000        96,000,000 93,000,000           213,000,000  1,339,000,000                                                   
        authorized—755 million shares, issued— 327 million shares at june 30, 2024 and 2023
             2,917,000,000                                                                             
        accumulated deficit
             -286,000,000 -289,000,000 -425,000,000 -654,000,000 -534,000,000 -342,000,000 -560,000,000 -301,000,000                                                                      
        common shares in treasury, at cost: 83 million shares and 76 million shares at june 30, 2024 and 2023, respectively
             -5,677,000,000                                                                             
        authorized—755 million shares, issued—327 million shares at march 31, 2024 and june 30, 2023
              2,887,000,000                                                                            
        common shares in treasury, at cost: 83 million shares and 76 million shares at march 31, 2024 and june 30, 2023, respectively
              -5,703,000,000                                                                            
        authorized—755 million shares, issued—327 million shares at december 31, 2023 and june 30, 2023
               2,855,000,000                                                                           
        common shares in treasury, at cost: 83 million shares and 76 million shares at december 31, 2023 and june 30, 2023, respectively
               -5,724,000,000                                                                           
        authorized—755 million shares, issued—327 million shares at september 30, 2023 and june 30,2023
                2,728,000,000                                                                          
        common shares in treasury, at cost: 80 million shares and 76 million shares at september 30, 2023 and june 30, 2023, respectively
                -5,400,000,000                                                                          
        authorized—755 million shares, issued— 327 million shares at june 30, 2023 and 2022
                 2,747,000,000                                                                         
        common shares in treasury, at cost: 76 million shares and 54 million shares at june 30, 2023 and 2022, respectively
                 -4,914,000,000                                                                         
        authorized—755 million shares, issued—327 million shares at march 31, 2023 and june 30, 2022
                  2,818,000,000                                                                        
        common shares in treasury, at cost: 72 million shares and 54 million shares at march 31, 2023 and june 30, 2022, respectively
                  -4,554,000,000                                                                        
        authorized—755 million shares, issued—327 million shares at december 31, 2022 and june 30, 2022
                   2,747,000,000                                                                       
        common shares in treasury, at cost: 68 million shares and 54 million shares at december 31, 2022 and june 30, 2022, respectively
                   -4,254,000,000                                                                       
        authorized—755 million shares, issued—327 million shares at september 30, 2022 and june 30,2022
                    2,576,000,000                                                                      
        common shares in treasury, at cost: 65 million shares and 54 million shares at september 30, 2022 and june 30, 2022, respectively
                    -3,880,000,000                                                                      
        liabilities and shareholders’ equity/
                                                                                          
        shareholders’ equity/
                                                                                          
        authorized—755 million shares, issued— 327 million shares at june 30, 2022 and 2021
                     2,813,000,000                                                                     
        common shares in treasury, at cost: 54 million shares and 36 million shares at june 30, 2022 and 2021, respectively
                     -3,128,000,000                                                                     
        total cardinal health, inc. shareholders' equity/
                     -709,000,000 -697,000,000                                                                    
        total shareholders’ equity/
                     -706,000,000 -693,000,000                                                                    
        total liabilities and shareholders’ equity/
                     43,878,000,000 42,111,000,000                                                                    
        authorized—755 million shares, issued—327 million shares at march 31, 2022 and june 30, 2021
                      2,761,000,000                                                                    
        common shares in treasury, at cost: 54 million shares and 36 million shares at march 31, 2022 and june 30, 2021, respectively
                      -3,100,000,000                                                                    
        liabilities and shareholders’ equity
                                                                                          
        shareholders’ equity:
                                                                                          
        authorized—755 million shares, issued—327 million shares at december 31, 2021 and june 30, 2021
                       2,721,000,000                                                                   
        common shares in treasury, at cost: 50 million shares and 36 million shares at december 31, 2021 and june 30, 2021, respectively
                       -2,883,000,000                                                                   
        total cardinal health, inc. shareholders' equity
                       998,000,000 1,393,000,000 1,791,000,000 1,790,000,000 1,971,000,000 1,422,000,000 1,789,000,000 1,203,000,000 999,000,000 900,000,000 6,328,000,000 6,230,000,000   6,059,000,000 7,537,000,000 7,599,000,000 6,678,000,000 6,808,000,000 6,646,000,000 6,323,000,000 6,512,000,000 6,554,000,000 6,713,000,000 6,711,000,000 6,505,000,000                                          
        total shareholders’ equity
                       1,002,000,000 1,396,000,000 1,794,000,000 1,794,000,000 1,975,000,000 1,425,000,000 1,792,000,000 1,206,000,000 1,002,000,000 903,000,000 6,330,000,000 6,232,000,000 6,043,000,000 5,913,000,000 6,059,000,000 7,538,000,000 7,619,000,000 6,695,000,000 6,828,000,000 6,665,000,000 6,341,000,000 6,531,000,000 6,571,000,000 6,730,000,000 6,728,000,000 6,527,000,000 6,256,000,000 6,369,000,000 6,100,000,000 6,256,000,000 6,401,000,000 6,532,000,000 6,589,000,000 6,297,000,000 5,975,000,000 6,830,000,000 6,542,000,000 6,281,000,000 6,244,000,000 6,240,100,000 5,927,700,000 5,713,900,000 5,848,600,000 5,656,800,000 5,421,400,000 5,239,000,000 5,276,100,000 5,360,900,000 5,226,100,000 4,941,200,000 8,724,700,000 8,434,500,000 8,127,900,000 7,918,100,000 7,747,500,000 7,393,200,000 7,108,100,000 7,068,200,000 7,376,900,000 7,869,400,000 8,907,800,000 8,421,100,000 8,490,700,000 8,586,800,000 8,751,000,000 8,878,900,000 8,593,000,000 
        total liabilities and shareholders’ equity
                       43,680,000,000 42,993,000,000 44,453,000,000 43,874,000,000 44,719,000,000 41,727,000,000 40,766,000,000 41,148,000,000 41,042,000,000 39,179,000,000                 30,142,000,000 27,888,000,000 27,248,000,000 25,711,000,000 26,033,000,000 24,701,000,000 25,009,000,000 23,816,000,000 25,819,000,000 26,723,000,000 24,642,000,000 24,820,000,000 24,260,000,000 24,642,100,000 24,263,200,000 23,183,000,000 22,845,900,000 23,196,800,000 22,849,700,000 20,972,500,000 19,990,200,000 21,270,200,000 20,821,500,000 20,434,700,000 25,118,800,000 25,534,800,000 25,014,800,000 24,645,100,000 23,448,200,000 23,603,400,000 23,466,800,000 22,998,100,000 23,153,800,000 24,292,000,000 24,137,200,000 23,431,200,000 23,374,100,000 23,645,600,000 23,230,200,000 22,969,900,000  
        authorized—755 million shares, issued—327 million shares at september 30, 2021 and june 30,2021
                        2,666,000,000                                                                  
        common shares in treasury, at cost: 43 million shares and 36 million shares at september 30, 2021 and june 30, 2021, respectively
                        -2,547,000,000                                                                  
        authorized—755 million shares, issued— 327 million shares at june 30, 2021 and 2020
                         2,806,000,000                                                                 
        common shares in treasury, at cost: 36 million shares and 34 million shares at june 30, 2021 and 2020, respectively
                         -2,186,000,000                                                                 
        authorized—755 million shares, issued—327 million shares at march 31, 2021 and june 30, 2020, respectively
                          2,807,000,000                                                                
        common shares in treasury, at cost: 36 million shares and 34 million shares at march 31, 2021 and june 30, 2020, respectively
                          -2,202,000,000                                                                
        authorized—755 million shares, issued—327 million shares at december 31, 2020 and june 30, 2020, respectively
                           2,778,000,000                                                               
        common shares in treasury, at cost: 33 million shares and 34 million shares at december 31, 2020 and june 30, 2020, respectively
                           -2,009,000,000                                                               
        authorized—755 million shares, issued—327 million shares at september 30, 2020 and june 30,2020, respectively
                            2,760,000,000                                                              
        common shares in treasury, at cost: 33 million shares and 34 million shares at september 30, 2020 and june 30, 2020, respectively
                            -2,022,000,000                                                              
        authorized—755 million shares, issued—327 million shares at june 30, 2020 and 2019, respectively
                             2,789,000,000                                                             
        common shares in treasury, at cost: 34 million shares and 28 million shares at june 30, 2020 and 2019, respectively
                             -2,066,000,000                                                             
        authorized—755 million shares, issued—327 million shares at march 31, 2020 and june 30, 2019, respectively
                              2,774,000,000                                                            
        common shares in treasury, at cost: 35 million shares and 28 million shares at march 31, 2020 and june 30, 2019, respectively
                              -2,086,000,000                                                            
        authorized—755 million shares, issued—327 million shares at december 31, 2019 and june 30, 2019, respectively
                               2,752,000,000                                                           
        common shares in treasury, at cost: 35 million shares and 28 million shares at december 31, 2019 and june 30, 2019, respectively
                               -2,099,000,000                                                           
        authorized—755 million shares, issued—327 million shares at september 30, 2019 and june 30, 2019, respectively
                                2,669,000,000                                                          
        common shares in treasury, at cost: 34 million shares and 28 million shares at september 30, 2019 and june 30, 2019, respectively
                                -2,039,000,000                                                          
        liabilities, redeemable noncontrolling interests and shareholders’ equity
                                                                                          
        redeemable noncontrolling interests
                                     12,000,000 12,000,000 13,000,000 12,000,000 118,000,000 117,000,000 115,000,000 116,000,000 117,000,000 117,000,000 120,000,000 119,000,000                                          
        authorized—755 million shares, issued—327 million shares at june 30, 2019 and 2018, respectively
                                 2,763,000,000                                                         
        common shares in treasury, at cost: 28 million shares and 18 million shares at june 30, 2019 and 2018, respectively
                                 -1,790,000,000                                                         
        total liabilities, redeemable noncontrolling interests and shareholders’ equity
                                 40,963,000,000 40,809,000,000 40,462,000,000 40,011,000,000 39,951,000,000 41,031,000,000 42,905,000,000 41,940,000,000 40,112,000,000 34,174,000,000 35,021,000,000                                               
        authorized—755 million shares, issued—327 million shares at march 31, 2019 and june 30, 2018, respectively
                                  2,748,000,000                                                        
        common shares in treasury, at cost: 29 million shares and 18 million shares at march 31, 2019 and june 30, 2018, respectively
                                  -1,793,000,000                                                        
        authorized—755 million shares, issued—327 million shares at december 31, 2018 and june 30, 2018, respectively
                                   2,728,000,000                                                       
        common shares in treasury, at cost: 29 million shares and 18 million shares at december 31, 2018 and june 30, 2018, respectively
                                   -1,795,000,000                                                       
        investments
                                    394,000,000                                                      
        authorized—755 million shares, issued—327 million shares at september 30, 2018 and june 30, 2018, respectively
                                    2,590,000,000                                                      
        common shares in treasury, at cost: 27 million shares and 18 million shares at september 30, 2018 and june 30, 2018, respectively
                                    -1,678,000,000                                                      
        authorized—755 million shares, issued—327 million shares at june 30, 2018 and june 30, 2017, respectively
                                     2,730,000,000                                                     
        common shares in treasury, at cost: 18 million shares and 11 million shares at june 30, 2018 and june 30, 2017, respectively
                                     -1,224,000,000                                                     
        authorized—755 million shares, issued—327 million shares at march 31, 2018 and june 30, 2017, respectively
                                      2,710,000,000                                                    
        common shares in treasury, at cost: 16 million shares and 11 million shares at march 31, 2018 and june 30, 2017, respectively
                                      -1,126,000,000                                                    
        authorized—755 million shares, issued—327 million shares at december 31, 2017 and june 30, 2017, respectively
                                       2,694,000,000                                                   
        common shares in treasury, at cost: 12 million shares and 11 million shares at december 31, 2017 and june 30, 2017, respectively
                                       -848,000,000                                                   
        authorized—755 million shares, issued—327 million shares and 327 million shares at september 30, 2017 and june 30, 2017, respectively
                                        2,674,000,000                                                  
        common shares in treasury, at cost: 12 million shares and 11 million shares at september 30, 2017 and june 30, 2017, respectively
                                        -853,000,000                                                  
        authorized—755 million shares, issued—327 million shares and 364 million shares at june 30, 2017 and 2016, respectively
                                         2,697,000,000                                                 
        common shares in treasury, at cost: 11 million shares and 42 million shares at june 30, 2017 and 2016, respectively
                                         -731,000,000                                                 
        authorized—755 million shares, issued—327 million shares and 364 million shares at march 31, 2017 and june 30, 2016, respectively
                                          2,684,000,000                                                
        common shares in treasury, at cost: 11 million shares and 42 million shares at march 31, 2017 and june 30 2016, respectively
                                          -744,000,000                                                
        authorized—755 million shares, issued—327 million shares and 364 million shares at december 31, 2016 and june 30, 2016, respectively
                                           2,672,000,000                                               
        common shares in treasury, at cost: 11 million shares and 42 million shares at december 31, 2016 and june 30 2016, respectively
                                           -783,000,000                                               
        liabilities, redeemable noncontrolling interests, and shareholders’ equity
                                                                                          
        authorized—755 million shares, issued—364 million shares at september 30, 2016 and june 30, 2016
                                            2,958,000,000                                              
        common shares in treasury, at cost: 44 million shares and 42 million shares at september 30, 2016 and june 30 2016, respectively
                                            -2,912,000,000                                              
        total liabilities, redeemable noncontrolling interests, and shareholders’ equity
                                            34,406,000,000 34,122,000,000 34,055,000,000 33,507,000,000 31,222,000,000                                          
        authorized—755 million shares, issued—364 million shares at june 30, 2016 and 2015
                                             3,010,000,000                                             
        common shares in treasury, at cost: 42 million shares and 36 million shares at june 30, 2016 and 2015, respectively
                                             -2,759,000,000                                             
        authorized—755 million shares, issued—364 million shares at march 31, 2016 and june 30, 2015
                                              2,995,000,000                                            
        common shares in treasury, at cost: 38 million shares and 36 million shares at march 31, 2016 and june 30, 2015, respectively
                                              -2,429,000,000                                            
        authorized—755 million shares, issued—364 million shares at december 31, 2015 and june 30, 2015
                                               2,973,000,000                                           
        common shares in treasury, at cost: 34 million shares and 36 million shares at december 31, 2015 and june 30, 2015, respectively
                                               -2,137,000,000                                           
        authorized—755 million shares, issued—364 million shares at september 30, 2015 and june 30, 2015
                                                2,957,000,000                                          
        common shares in treasury, at cost: 35 million shares and 36 million shares at september 30, 2015 and june 30, 2015, respectively
                                                -2,158,000,000                                          
        authorized—755 million shares, issued—364 million shares at june 30, 2015 and 2014
                                                 3,003,000,000                                         
        common shares in treasury, at cost: 36 million shares and 27 million shares at june 30, 2015 and 2014, respectively
                                                 -2,245,000,000                                         
        accumulated other comprehensive income/
                                                 -23,000,000                                         
        authorized—755 million shares, issued—364 million shares at march 31, 2015 and june 30, 2014
                                                  2,992,000,000                                        
        common shares in treasury, at cost: 33 million shares and 27 million shares at march 31, 2015 and june 30, 2014, respectively
                                                  -1,923,000,000                                        
        accumulated other comprehensive income
                                                  -53,000,000 -3,000,000 46,000,000 70,000,000 70,000,000 99,000,000 92,000,000 68,000,000 56,000,000 74,000,000 61,000,000 37,000,000 71,700,000 55,100,000 60,000,000 76,700,000 67,100,000 39,400,000 37,200,000 70,000,000 172,200,000 200,400,000 76,900,000 82,200,000 32,600,000 41,300,000 136,400,000 210,800,000 202,800,000 154,500,000 146,100,000 121,000,000 127,200,000 90,200,000       
        authorized—755 million shares, issued—364 million shares at december 31, 2014 and june 30, 2014
                                                   2,973,000,000                                       
        common shares in treasury, at cost: 34 million shares and 27 million shares at december 31, 2014 and june 30, 2014, respectively
                                                   -1,970,000,000                                       
        authorized—755 million shares, issued—364 million shares at september 30, 2014 and june 30, 2014
                                                    2,948,000,000                                      
        common shares in treasury, at cost: 30 million shares and 27 million shares at september 30, 2014 and june 30, 2014, respectively
                                                    -1,663,000,000                                      
        authorized—755 million shares, issued—364 million shares at june 30, 2014 and 2013
                                                     2,980,000,000                                     
        common shares in treasury, at cost: 27 million shares and 25 million shares at june 30, 2014 and 2013, respectively
                                                     -1,423,000,000                                     
        authorized—755 million shares, issued—364 million shares at march 31, 2014 and june 30, 2013
                                                      2,959,000,000                                    
        common shares in treasury, at cost: 23 million shares and 25 million shares at march 31, 2014 and june 30, 2013, respectively
                                                      -1,154,000,000                                    
        authorized—755 million shares, issued—364 million shares at december 31, 2013 and june 30, 2013
                                                       2,961,000,000                                   
        common shares in treasury, at cost: 21 million shares and 25 million shares at december 31, 2013 and june 30, 2013, respectively
                                                       -917,000,000                                   
        authorized—755 million shares, issued—364 million shares at september 30, 2013 and june 30, 2013
                                                        2,941,000,000                                  
        common shares in treasury, at cost: 23 million shares and 25 million shares at september 30, 2013 and june 30, 2013, respectively
                                                        -1,009,000,000                                  
        authorized—755 million shares, issued—364 million shares at june 30, 2013 and 2012
                                                         2,953,000,000                                 
        common shares in treasury, at cost: 25 million shares and 21 million shares at june 30, 2013 and 2012, respectively
                                                         -1,084,000,000                                 
        authorized—755 million shares, issued—364 million shares at march 31, 2013 and june 30, 2012
                                                          2,936,000,000                                
        common shares in treasury, at cost: 22 million shares and 21 million shares at march 31, 2013 and june 30, 2012, respectively
                                                          -904,000,000                                
        authorized—755 million shares, issued—364 million shares at december 31, 2012 and june 30, 2012
                                                           2,929,000,000                               
        common shares in treasury, at cost: 23 million shares and 21 million shares at december 31, 2012 and june 30, 2012, respectively
                                                           -952,000,000                               
        authorized—755 million shares, issued—364 million shares at september 30, 2012 and june 30, 2012
                                                            2,927,000,000                              
        common shares in treasury, at cost: 24 million shares and 21 million shares at september 30, 2012 and june 30, 2012, respectively
                                                            -989,000,000                              
        other
                                                             807,000,000 683,700,000 725,700,000 716,500,000 758,800,000 775,900,000 805,300,000 682,100,000 657,800,000 719,800,000 747,900,000 735,400,000 421,100,000 430,300,000 619,000,000 468,400,000 384,100,000 457,600,000 395,300,000 328,500,000 280,700,000 304,400,000 290,400,000 325,100,000 266,300,000 340,300,000 311,900,000 408,000,000 341,300,000 
        authorized—755 million shares, issued—364 million shares at june 30, 2012 and 2011
                                                             2,930,000,000                             
        common shares in treasury, at cost: 21 million shares and 12 million shares at june 30, 2012 and 2011, respectively
                                                             -816,000,000                             
        property and equipment, at cost
                                                              3,449,500,000 3,382,700,000 3,304,800,000  3,288,300,000 3,213,000,000 3,151,600,000  3,118,000,000 3,105,900,000 3,045,800,000  3,685,300,000 3,611,000,000 3,619,200,000  3,785,000,000 3,726,100,000 3,641,400,000  3,365,500,000 3,306,300,000 5,044,500,000  4,807,400,000 4,781,300,000 4,685,500,000  
        accumulated depreciation and amortization
                                                              -1,932,100,000 -1,868,600,000 -1,810,800,000 -1,762,000,000 -1,818,500,000 -1,728,200,000 -1,676,300,000 -1,624,900,000 -1,711,900,000 -1,682,700,000 -1,607,200,000 -2,010,800,000 -1,961,300,000 -1,881,400,000 -1,869,700,000 -1,995,600,000 -2,105,500,000 -2,045,400,000 -1,958,300,000 -1,890,200,000 -1,831,800,000 -1,787,800,000 -2,470,400,000 -2,476,600,000 -2,318,300,000 -2,291,300,000 -2,235,900,000 -2,184,600,000 
        other assets:
                                                                                          
        authorized—0.5 million shares, issued—none
                                                                                          
        authorized—755.0 million shares, issued—363.6 million shares at march 31, 2012 and june 30, 2011
                                                              2,921,500,000                            
        common shares in treasury, at cost: 17.6 million shares and 12.5 million shares at march 31, 2012 and june 30, 2011, respectively
                                                              -691,900,000                            
        authorized—755.0 million shares, issued—363.6 million shares at december 31, 2011 and june 30, 2011
                                                               2,900,400,000                           
        common shares in treasury, at cost: 18.0 million shares and 12.5 million shares at december 31, 2011 and june 30, 2011, respectively
                                                               -707,600,000                           
        authorized—755.0 million shares, issued—363.6 million shares at september 30, 2011 and june 30, 2011
                                                                2,886,500,000                          
        common shares in treasury, at cost: 18.4 million shares and 12.5 million shares at september 30, 2011 and june 30, 2011, respectively
                                                                -725,200,000                          
        property and equipment, at cost:
                                                                                          
        land, buildings and improvements
                                                                 1,105,100,000    1,121,500,000    1,288,300,000    1,099,600,000    1,694,000,000    1,837,200,000    1,647,500,000 
        machinery and equipment
                                                                 2,055,100,000    1,868,800,000    2,454,400,000    2,487,300,000    1,657,400,000    3,055,700,000    2,868,300,000 
        furniture and fixtures
                                                                 114,000,000    103,400,000    141,100,000    145,900,000    185,800,000    167,700,000    152,800,000 
        total property and equipment, at cost
                                                                 3,274,200,000    3,093,700,000    3,883,800,000    3,732,800,000    3,537,200,000    5,060,600,000    4,668,600,000 
        investment in carefusion
                                                                     691,500,000 805,200,000 897,400,000 902,400,000                  
        authorized—755.0 million shares, issued—363.6 million shares at june 30, 2011 and 2010, respectively
                                                                 2,898,200,000                         
        common shares in treasury, at cost: 12.5 million shares and 7.2 million shares at june 30, 2011 and 2010, respectively
                                                                 -457,700,000                         
        authorized—755.0 million shares, issued— 363.6 million shares at march 31, 2011 and june 30, 2010
                                                                  2,887,100,000                        
        common shares in treasury, at cost: 13.3 million shares and 7.2 million shares at march 31, 2011 and june 30, 2010, respectively
                                                                  -487,200,000                        
        authorized—755.0 million shares, issued— 363.6 million shares at december 31, 2010 and june 30, 2010
                                                                   2,876,700,000                       
        common shares in treasury, at cost: 14.2 million shares and 7.2 million shares at december 31, 2010 and june 30, 2010, respectively
                                                                   -518,400,000                       
        authorized—755.0 million shares, issued—363.6 million shares at september 30, 2010 and june 30, 2010
                                                                    2,865,600,000                      
        common shares in treasury, at cost: 14.7 million shares and 7.2 million shares at september 30, 2010 and june 30, 2010, respectively
                                                                    -539,800,000                      
        assets from businesses held for sale and discontinued operations
                                                                      138,900,000 148,900,000 162,600,000 174,700,000                 
        liabilities from businesses held for sale and discontinued operations
                                                                      35,300,000 37,300,000 35,600,000 26,300,000 2,400,000 2,400,000 2,400,000 15,400,000 20,600,000 3,600,000 5,200,000 34,200,000 518,300,000 529,400,000 10,900,000 80,400,000 155,200,000    
        preferred shares, without par value: authorized—0.5 million shares, issued—none
                                                                                          
        common shares, without par value: authorized—755.0 million shares, issued—363.6 million shares and 363.7 million shares at june 30, 2010 and 2009, respectively
                                                                     2,889,900,000                     
        common shares in treasury, at cost: 7.2 million shares and 3.7 million shares at june 30, 2010 and 2009, respectively
                                                                     -331,000,000                     
        long-term obligations, less current portion and other short-term borrowings
                                                                      1,875,600,000 2,099,200,000 2,103,500,000 3,280,000,000 3,303,100,000 3,389,200,000  3,687,400,000 3,450,100,000 3,396,500,000 3,347,500,000 3,457,300,000 2,899,000,000 2,935,800,000 2,627,400,000 2,599,700,000 2,548,200,000 2,568,300,000 2,204,000,000 2,319,900,000 
        preferred shares, without par value: authorized – 0.5 million shares, issued – none
                                                                                          
        common shares, without par value: authorized – 755.0 million shares, issued – 363.6 million shares and 363.7 million shares at march 31, 2010 and june 30, 2009, respectively
                                                                      2,897,200,000                    
        common shares in treasury, at cost: 1.9 million shares and 3.7 million shares at march 31, 2010 and june 30, 2009, respectively
                                                                      -172,400,000                    
        common shares, without par value: authorized – 755.0 million shares, issued – 363.6 million shares and 363.7 million shares at december 31, 2009 and june 30, 2009, respectively
                                                                       2,893,000,000                   
        common shares in treasury, at cost, 2.3 million shares and 3.7 million shares at december 31, 2009 and june 30, 2009, respectively
                                                                       -173,800,000                   
        common shares, without par value: authorized – 755.0 million shares, issued – 363.6 million shares and 363.7 million shares at september 30, 2009 and june 30, 2009, respectively
                                                                        2,929,100,000                  
        common shares in treasury, at cost, 1.1 million shares and 3.7 million shares at september 30, 2009 and june 30, 2009, respectively
                                                                        -188,900,000                  
        current portion of net investment in sales-type leases
                                                                         398,900,000 402,700,000 388,800,000 384,800,000 383,700,000 381,200,000 378,300,000 369,100,000 354,800,000 337,100,000 330,300,000 309,300,000 290,100,000 273,700,000 260,500,000 252,100,000 238,200,000 
        net investment in sales-type leases, less current portion
                                                                         929,800,000 934,100,000 946,600,000 935,800,000 916,800,000 878,200,000 855,900,000 830,500,000 820,700,000 784,600,000 758,900,000 756,300,000 754,700,000 740,000,000 733,100,000 718,300,000 693,800,000 
        preferred shares, without par value
                                                                                          
        common shares, without par value
                                                                                          
        authorized—755.0 million shares, issued—363.7 million shares and 364.7 million shares at june 30, 2009 and 2008, respectively
                                                                         3,031,600,000                 
        common shares in treasury, at cost, 3.7 million shares and 7.6 million shares at june 30, 2009 and 2008, respectively
                                                                         -343,000,000                 
        deferred income taxes and other accrued liabilities
                                                                          1,549,900,000                
        common shares, without par value: authorized – 755.0 million shares, issued – 364.5 million shares and 364.7 million shares at march 31, 2009 and june 30, 2008, respectively
                                                                          3,006,700,000                
        common shares in treasury, at cost, 4.1 million shares and 7.6 million shares at march 31, 2009 and june 30, 2008 , respectively
                                                                          -348,500,000                
        preferred shares, without par value: authorized – 0.5 million shares, issued–none
                                                                                          
        common shares, without par value: authorized – 755.0 million shares, issued – 364.5 million shares and 364.7 million shares at december 31, 2008 and june 30, 2008, respectively
                                                                           3,005,100,000               
        common shares in treasury, at cost, 4.9 million shares and 7.6 million shares at december 31, 2008 and june 30, 2008 , respectively
                                                                           -399,900,000               
        common shares, without par value: authorized – 755.0 million shares, issued – 364.5 million shares and 364.7 million shares at september 30, 2008 and june 30, 2008, respectively
                                                                            2,962,600,000              
        common shares in treasury, at cost, 5.0 million shares and 7.6 million shares at september 30, 2008 and june 30, 2008 , respectively
                                                                            -396,100,000              
        short-term investments available for sale
                                                                                 132,000,000 300,000,000 467,100,000 456,500,000 498,400,000 499,200,000 419,000,000 199,900,000 99,800,000 
        authorized—755.0 million shares, issued—364.7 million shares and 493.0 million shares at june 30, 2008 and 2007, respectively
                                                                             3,001,200,000             
        common shares in treasury, at cost, 7.6 million shares and 124.9 million shares at june 30, 2008 and 2007, respectively
                                                                             -480,700,000             
        common shares, without par value: authorized – 755.0 million shares, issued – 364.8 million shares and 493.0 million shares, respectively, at march 31, 2008 and june 30, 2007
                                                                              2,948,500,000            
        common shares in treasury, at cost, 8.1 million shares and 124.9 million shares, respectively, at march 31, 2008 and june 30, 2007
                                                                              -506,300,000            
        preferred shares, without par value; authorized – 0.5 million shares, issued–none
                                                                                          
        common shares, without par value; authorized – 755.0 million shares, issued – 364.8 million shares and 493.0 million shares, respectively, at december 31, 2007 and june 30, 2007
                                                                               2,936,000,000           
        common shares in treasury, at cost, 6.6 million shares and 124.9 million shares, respectively, at december 31, 2007 and june 30, 2007
                                                                               -418,900,000           
        preferred shares, without par value; authorized – 0.5 million shares, issued—none
                                                                                          
        common shares, without par value; authorized – 755.0 million shares, issued – 492.5 million shares and 493.0 million shares, respectively, at september 30, 2007 and june 30, 2007
                                                                                3,957,700,000          
        common shares in treasury, at cost, 130.0 million shares and 124.9 million shares, respectively, at september 30, 2007 and june 30, 2007
                                                                                -8,694,200,000          
        assets held for sale and discontinued operations
                                                                                  3,118,100,000 3,093,900,000 63,400,000 212,600,000 316,000,000    
        authorized — 0.5 million shares, issued — none
                                                                                          
        authorized — 755.0 million shares, issued — 493.0 million shares and 482.3 million shares at june 30, 2007 and 2006, respectively
                                                                                 3,931,300,000         
        common shares in treasury, at cost, 124.9 million shares and 71.5 million shares at june 30, 2007 and 2006, respectively
                                                                                 -8,215,300,000         
        cash and cash equivalents
                                                                                  866,500,000        
        preferred shares, without par value: authorized – 0.5 million shares, issued—none
                                                                                          
        common shares, without par value: authorized – 755.0 million shares, issued – 488.7 million shares and 482.3 million shares, respectively, at march 31, 2007 and june 30, 2006
                                                                                  3,635,600,000        
        common shares in treasury, at cost, 101.9 million shares and 71.5 million shares, respectively, at march 31, 2007 and june 30, 2006
                                                                                  -6,574,700,000        
        common shares, without par value: authorized – 755.0 million shares, issued – 484.6 million shares and 482.3 million shares, respectively, at december 31, 2006 and june 30, 2006
                                                                                   3,355,200,000       
        common shares in treasury, at cost, 82.9 million shares and 71.5 million shares, respectively, at december 31, 2006 and june 30, 2006
                                                                                   -5,230,100,000       
        preferred shares, without par value authorized – 0.5 million shares, issued—none
                                                                                          
        common shares, without par value authorized – 755.0 million shares, issued – 484.0 million shares and 482.3 million shares, respectively, at september 30, 2006 and june 30, 2006
                                                                                    3,295,200,000      
        common shares in treasury, at cost, 78.2 million shares and 71.5 million shares, respectively, at september 30, 2006 and june 30, 2006
                                                                                    -4,929,200,000      
        other comprehensive income
                                                                                    60,600,000 33,900,000 -6,100,000 -23,900,000 7,500,000 20,200,000 
        preferred shares, without par value authorized - 0.5 million shares, issued - none
                                                                                          
        common shares, without par value authorized - 755.0 million shares, issued - 482.3 million shares and 476.5 million shares at june 30, 2006 and 2005, respectively
                                                                                     3,195,500,000     
        common shares in treasury, at cost, 71.5 million shares and 50.3 million shares at june 30, 2006 and 2005, respectively
                                                                                     -4,499,200,000     
        preferred shares, without par value authorized – 0.5 million shares, issued — none
                                                                                          
        common shares, without par value authorized – 755.0 million shares, issued – 481.7 million shares and 476.5 million shares, respectively, at march 31, 2006 and june 30, 2005
                                                                                      3,113,800,000    
        common shares in treasury, at cost, 64.1 million shares and 50.3 million shares, respectively, at march 31, 2006 and june 30, 2005
                                                                                      -3,998,300,000    
        assets held for sale from discontinued operations
                                                                                       26,600,000 34,700,000  
        liabilities from discontinued operations
                                                                                       8,800,000 9,400,000  
        common shares, without par value authorized – 755.0 million shares, issued – 479.0 million shares and 476.5 million shares, respectively, at december 31, 2005 and june 30, 2005
                                                                                       2,912,200,000   
        common shares in treasury, at cost, 57.1 million shares and 50.3 million shares, respectively, at december 31, 2005 and june 30, 2005
                                                                                       -3,491,600,000   
        preferred shares, without par value authorized — 0.5 million shares, issued — none
                                                                                          
        common shares, without par value authorized — 755.0 million shares, issued — 477.9 million shares and 476.5 million shares, respectively, at september 30, 2005 and june 30, 2005
                                                                                        2,812,900,000  
        common shares in treasury, at cost, 49.9 million shares and 50.3 million shares, respectively, at september 30, 2005 and june 30, 2005
                                                                                        -3,019,800,000  
        authorized — 755.0 million shares, issued — 476.5 million shares and 473.1 million shares at june 30, 2005 and 2004, respectively
                                                                                         2,765,500,000 
        common shares in treasury, at cost, 50.3 million shares and 42.2 million shares at june 30, 2005 and 2004, respectively
                                                                                         -3,043,600,000 
        total liabilities and shareholders' equity
                                                                                         22,059,200,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-09-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 
                                                                                         
          cash flows from operating activities:
                                                                                         
          net earnings
        454,000,000 380,000,000 471,000,000 454,000,000 243,000,000 508,000,000 401,000,000 417,000,000 234,000,000 259,000,000 354,000,000 6,000,000 -66,000,000 347,000,000 -130,000,000 111,000,000 137,000,000 -1,390,000,000 49,000,000 272,000,000 115,000,000 120,000,000   657,000,000 351,000,000 220,000,000 -4,921,000,000 195,000,000 1,053,000,000 117,000,000 -1,166,000,000 791,000,000 324,000,000 310,000,000 278,000,000 306,000,000 400,000,000 310,000,000 335,000,000 295,000,000 365,000,000 289,000,000 266,000,000 234,000,000 315,000,000 278,000,000 339,000,000 -586,000,000 345,000,000 304,000,000 271,000,000 236,800,000 333,400,000 262,000,000 236,800,000 202,700,000 246,100,000 215,400,000 294,800,000 223,500,000 222,400,000 234,500,000 -38,200,000 273,200,000 312,800,000 316,500,000 249,100,000 318,000,000 356,100,000 324,700,000 301,800,000 902,200,000 18,900,000 739,300,000 270,700,000 321,000,000    
          adjustments to reconcile net earnings to net cash provided by/(used in) operating activities:
                                                                                         
          depreciation and amortization
        233,000,000 248,000,000 234,000,000 233,000,000 209,000,000 207,000,000 192,000,000 182,000,000 186,000,000 177,000,000 175,000,000 172,000,000 176,000,000 175,000,000 170,000,000 171,000,000 179,000,000 181,000,000 164,000,000 168,000,000 180,000,000 199,000,000 199,000,000 205,000,000 225,000,000 224,000,000 230,000,000 234,000,000 241,000,000 239,000,000 291,000,000 229,000,000 253,000,000 440,000,000 166,000,000 173,000,000 192,000,000 219,000,000 133,000,000 173,000,000 176,000,000 115,000,000 116,000,000 112,000,000 108,000,000 115,000,000 110,000,000 117,000,000 117,000,000 122,000,000 99,000,000 88,000,000 88,000,000 85,700,000 83,500,000 77,600,000 78,200,000 74,100,000 97,500,000 73,200,000 68,500,000 60,000,000 68,600,000 59,500,000 66,300,000 106,000,000 92,900,000 99,500,000 101,000,000 96,400,000 93,000,000 97,000,000 94,900,000 85,000,000 81,700,000 51,200,000 104,200,000 101,600,000 89,800,000 98,200,000 103,100,000 
          impairments and loss on sale of other investments
        5,000,000 15,000,000 5,000,000 1,000,000           21,000,000            1,000,000 -4,000,000 6,000,000 3,000,000                                                
          impairments and (gain)/loss on disposal of assets
        2,000,000                                        4,000,000                                         
          share-based compensation
        93,000,000 129,000,000 87,000,000 93,000,000 153,000,000 31,000,000 30,000,000 30,000,000 33,000,000 31,000,000 28,000,000 29,000,000 27,000,000 21,000,000 25,000,000 23,000,000 16,000,000 23,000,000 18,000,000 24,000,000 5,000,000 33,000,000 23,000,000 28,000,000 22,000,000 27,000,000 21,000,000 20,000,000 18,000,000 24,000,000 23,000,000 17,000,000 21,000,000 17,000,000 24,000,000 23,000,000 23,000,000 17,000,000 33,000,000 23,000,000 29,000,000 30,000,000 27,000,000 28,000,000 25,000,000 24,000,000 24,000,000 24,000,000 24,000,000 25,000,000 22,000,000 22,000,000 24,000,000 21,900,000 21,600,000 21,700,000 19,800,000 19,100,000 18,000,000 21,000,000 21,400,000                     
          benefit from bad debts
        13,000,000                             10,000,000 24,000,000 25,000,000 35,000,000 47,000,000 22,000,000 7,000,000   28,000,000 7,000,000 22,000,000        12,000,000                                 
          change in operating assets and liabilities, net of effects from acquisitions and divestitures:
                                                                                         
          (increase)/decrease in trade receivables
        -539,000,000                                                                                 
          increase in inventories
        -736,000,000 2,094,000,000 -2,543,000,000 -736,000,000  758,000,000 -1,289,000,000 -678,000,000  1,165,000,000 -1,479,000,000 -1,057,000,000 672,000,000 631,000,000 -1,379,000,000 -264,000,000 -149,000,000 -561,000,000 -232,000,000 -129,000,000 -261,000,000 -67,000,000   -401,000,000 983,000,000   -206,000,000 650,000,000 -614,000,000 -381,000,000 -346,000,000 429,000,000 -996,000,000 -298,000,000 337,000,000 555,000,000 -1,267,000,000 -298,000,000          -27,000,000 193,000,000 -329,000,000 -207,000,000  682,700,000 -1,391,700,000 -160,900,000  552,200,000 -868,500,000 -731,800,000   -1,099,100,000 -28,100,000                -2,900,000 
          increase/(decrease) in accounts payable
        2,147,000,000                                                -1,852,000,000                                 
          other accrued liabilities and operating items
        -699,000,000 -63,000,000 89,000,000 -699,000,000 -72,000,000 107,000,000 -133,000,000 -508,000,000 437,000,000 164,000,000 -86,000,000 -948,000,000 -122,000,000 219,000,000 -138,000,000 -926,000,000 499,000,000 1,636,000,000 -1,347,000,000 -495,000,000 -567,000,000 515,000,000 -81,000,000 585,000,000 1,125,000,000 297,000,000 -83,000,000 5,211,000,000 -116,000,000 1,199,000,000 -1,119,000,000 229,000,000 714,000,000 193,000,000 -442,000,000 -87,000,000 -193,000,000 -155,000,000 -85,000,000 -87,000,000 -121,000,000 -16,000,000 56,000,000 209,000,000 -96,000,000 -139,000,000 201,000,000 5,000,000 -183,000,000 -447,000,000 263,000,000 -93,000,000 -4,000,000 -270,900,000 187,100,000 -32,500,000 -12,700,000 -185,600,000 221,500,000 -197,500,000 -125,400,000   -159,400,000 -99,600,000 74,600,000 264,500,000 -282,800,000 -49,800,000 -89,400,000   56,900,000 -667,500,000 573,600,000 -47,400,000 177,100,000 -500,000 37,000,000 -76,300,000 137,800,000 
          net cash provided by/(used in) operating activities
        973,000,000                                   104,000,000    104,000,000                                          
          cash flows from investing activities:
                                                                                         
          acquisition of subsidiaries, net of cash acquired
        -41,000,000 -42,000,000 -1,884,000,000 -41,000,000 -1,395,000,000 -2,779,000,000   2,000,000                 -44,000,000 6,103,000,000 -2,000,000 -6,139,000,000 -6,131,000,000 -2,000,000 -9,000,000 -19,000,000 3,171,000,000 -3,275,000,000 -9,000,000 -231,000,000 -184,000,000 -233,000,000 -25,000,000 -61,000,000 -351,000,000 -118,000,000 -25,000,000 -25,000,000 -20,000,000 -2,093,000,000 -26,000,000 -100,000,000 -31,400,000 -135,300,000 -7,300,000   -1,735,100,000 -559,900,000                     
          additions to property and equipment
        -108,000,000 -146,000,000 -131,000,000 -108,000,000 -232,000,000 -126,000,000 -99,000,000 -90,000,000 -193,000,000 -112,000,000 -114,000,000 -92,000,000 -217,000,000 -109,000,000 -85,000,000 -70,000,000 -164,000,000 -82,000,000 -74,000,000 -67,000,000 -126,000,000 -100,000,000 -96,000,000 -78,000,000 -136,000,000 -90,000,000 -77,000,000 -72,000,000 -136,000,000 -24,000,000 -101,000,000 -67,000,000 -138,000,000 -33,000,000 -113,000,000 -100,000,000 -94,000,000 -118,000,000 -75,000,000 -100,000,000 -181,000,000 -161,000,000 -56,000,000 -47,000,000 -36,000,000 -111,000,000 -48,000,000 -64,000,000 -26,000,000 -92,000,000 -41,000,000 -36,000,000 -26,000,000 -104,000,000 -57,700,000 -57,000,000 -44,300,000 -105,300,000 -59,900,000 -64,100,000 -62,000,000   -42,900,000 -37,000,000 -270,300,000 -80,900,000   -124,500,000 -79,500,000 -80,600,000 -91,500,000 -114,300,000 -89,100,000 -68,700,000 -85,300,000 -112,700,000 -112,300,000 -142,200,000 -76,000,000 
          other investing items
        7,000,000 -20,000,000 4,000,000 7,000,000                                                                              
          net cash from investing activities
        -142,000,000 -181,000,000 -1,980,000,000 -142,000,000 -1,631,000,000 -2,898,000,000 -976,000,000 -88,000,000 166,000,000 -1,847,000,000 -105,000,000 -63,000,000 -206,000,000 -91,000,000 -87,000,000 -70,000,000 -204,000,000 -44,000,000 -47,000,000 862,000,000 -88,000,000 -99,000,000 -97,000,000 -94,000,000 742,000,000 -98,000,000 -78,000,000 -73,000,000   -105,000,000 -6,144,000,000 -140,000,000 -5,231,000,000 -127,000,000 -110,000,000 24,000,000 3,042,000,000 -3,361,000,000 -110,000,000 -399,000,000 -463,000,000 -286,000,000 -19,000,000 -81,000,000 -564,000,000 -146,000,000 -89,000,000 -51,000,000 -118,000,000 -2,140,000,000 -14,000,000 -103,000,000 -110,900,000 -182,000,000 -42,500,000 -41,600,000 -100,200,000 -74,400,000 -1,937,500,000 84,100,000 21,500,000 88,100,000 91,600,000 -74,100,000 -273,900,000 -92,900,000 -81,400,000 -94,700,000 -578,000,000 -76,400,000 -26,800,000 -45,200,000 1,807,300,000 -31,800,000 -154,400,000 -83,900,000 -361,800,000 -223,300,000 -429,900,000 -172,200,000 
          cash flows from financing activities:
                                                                                         
          proceeds from long-term obligations, net of issuance costs
        989,000,000 2,000,000 989,000,000 800,000,000                       -2,000,000           1,490,000,000                    -24,400,000 3,100,000 13,200,000 8,500,000   900,000 100,000 601,700,000 840,500,000 11,200,000 84,100,000 2,500,000 502,500,000 5,900,000 
          reduction of long-term obligations
        -512,000,000 -113,000,000 -12,000,000 -512,000,000 -11,000,000 -11,000,000 -414,000,000 -9,000,000 -760,000,000 -8,000,000 -8,000,000 -7,000,000 -8,000,000 -558,000,000 -6,000,000 -7,000,000 -288,000,000 -5,000,000 -5,000,000 -587,000,000 -517,000,000 -4,000,000 -9,000,000 -40,000,000 -511,000,000 -95,000,000 -719,000,000 -74,000,000 -1,099,000,000 400,000,000 -1,000,000 -402,000,000 -551,000,000 -343,000,000 -59,000,000 -1,000,000 -250,000,000 -56,000,000 -3,000,000 -1,000,000 -1,000,000 -1,000,000   -1,000,000   -299,000,000 -2,000,000 -4,000,000 -206,500,000 -43,500,000 -500,000 -500,000 -500,000 -218,700,000 -9,000,000 -400,000   -350,500,000 -1,134,400,000 5,500,000 -3,000,000 -154,500,000 -152,600,000 -5,600,000 -1,800,000 -1,100,000 -13,000,000 -51,100,000 -43,700,000 -659,700,000 -29,500,000 -45,400,000 -160,900,000 -96,100,000 -3,700,000 
          purchases/(payments) of noncontrolling interests
        -3,000,000   -3,000,000                                                                              
          net tax withholding from share-based compensation
        -80,000,000 2,000,000 -1,000,000 -80,000,000    -28,000,000                                                                          
          dividends on common shares
        -129,000,000 -120,000,000 -122,000,000 -129,000,000 -120,000,000 -124,000,000 -122,000,000 -128,000,000 -122,000,000 -122,000,000 -124,000,000 -131,000,000 -126,000,000 -128,000,000 -129,000,000 -142,000,000 -134,000,000 -136,000,000 -140,000,000 -149,000,000 -141,000,000 -143,000,000 -143,000,000 -146,000,000 -141,000,000 -141,000,000 -141,000,000 -146,000,000 -142,000,000 -139,000,000 -146,000,000 -150,000,000 -145,000,000 -143,000,000 -144,000,000 -149,000,000 -142,000,000 -176,000,000 -110,000,000 -149,000,000 -126,000,000 -114,000,000 -113,000,000 -114,000,000 -119,000,000 -103,000,000 -104,000,000 -103,000,000 -105,000,000 -95,000,000 -93,000,000 -81,000,000 -84,000,000 -74,100,000 -74,300,000 -74,400,000 -77,200,000 -68,300,000 -67,900,000 -67,700,000 -70,300,000   -63,000,000 -64,200,000 -50,300,000 -50,100,000 -50,200,000 -49,800,000 -42,700,000 -42,700,000 -43,400,000 -44,300,000 -34,900,000 -36,100,000 -36,400,000 -37,000,000 -25,200,000 -25,400,000 -25,700,000 -25,500,000 
          purchase of treasury shares
        -375,000,000 -250,000,000 -383,000,000 -375,000,000 -375,000,000 -15,000,000 -375,000,000 -250,000,000 -500,000,000 -500,000,000 -250,000,000 -250,000,000 -1,000,000,000 -200,000,000 -300,000,000 -500,000,000    -350,000,000 -450,000,000 -150,000,000 -100,000,000 150,000,000 -350,000,000 -250,000,000   -250,000,000 -351,000,000 -350,000,000 -326,000,000 -360,000,000 -284,000,000 -339,000,000 -50,000,000 -250,000,000 -200,000,000 -150,000,000 -300,000,000 -269,800,000            -674,700,000 -1,636,800,000 -1,279,900,000 -300,000,000 -445,300,000 -526,900,000 -560,100,000   
          net cash from financing activities
        -110,000,000 -483,000,000 -519,000,000 -110,000,000 656,000,000 -507,000,000 2,331,000,000 -540,000,000 -859,000,000 1,031,000,000 -353,000,000 -666,000,000 -592,000,000 -934,000,000 -362,000,000 -1,163,000,000 -415,000,000 -340,000,000 -444,000,000 -1,264,000,000 -649,000,000 -324,000,000 -146,000,000 -198,000,000 -528,000,000 -912,000,000 -175,000,000 -585,000,000 -1,243,000,000 -220,000,000 -86,000,000 -744,000,000  -581,000,000 -536,000,000 -350,000,000  -792,000,000 128,000,000 -350,000,000   -70,000,000 -522,000,000 -376,000,000   40,000,000 -48,000,000 -586,000,000 1,201,000,000 -41,000,000 -299,000,000 81,700,000 -98,500,000 -55,900,000 -381,300,000 -52,100,000 -225,800,000 429,500,000 -344,200,000   -454,200,000 31,300,000 -72,300,000 -134,600,000 -89,800,000 -171,500,000 98,000,000 -466,200,000 -52,200,000 -382,800,000 -1,178,300,000 -876,400,000 -238,400,000 -345,700,000 -514,300,000 -557,800,000 16,000,000 23,900,000 
          effect of exchange rates changes on cash and equivalents
        -2,000,000   -2,000,000    9,000,000             3,000,000 -6,000,000   -12,000,000 4,000,000   3,000,000 -9,000,000 -2,000,000 9,000,000 -13,000,000 27,000,000 -11,000,000 1,000,000 3,000,000   1,000,000                                          
          net increase/(decrease) in cash and equivalents
        719,000,000                                        -242,000,000                                         
          cash and equivalents at beginning of period
        3,874,000,000 3,874,000,000 5,133,000,000 33,000,000 4,043,000,000 4,717,000,000 3,407,000,000 2,771,000,000 2,531,000,000 -5,116,000,000 6,879,000,000 4,523,000,000 2,356,000,000 -2,260,000,000 2,260,000,000 2,356,000,000 2,865,000,000 1,901,000,000 2,274,000,000  1,929,300,000  2,755,300,000  1,221,600,000  1,291,300,000  1,308,800,000  1,000,000 -134,600,000 1,320,900,000  -1,200,000 1,401,200,000 
          cash and equivalents at end of period
        4,593,000,000 1,160,000,000 -1,816,000,000 4,593,000,000 548,000,000 -484,000,000 943,000,000 2,867,000,000 1,415,000,000 -873,000,000 737,000,000 3,854,000,000 53,000,000 336,000,000 162,000,000 3,492,000,000 2,361,000,000 -805,000,000 698,000,000 2,463,000,000 -92,000,000 -238,000,000 991,000,000 2,746,000,000 442,000,000 670,000,000 447,000,000 1,212,000,000 -907,000,000 2,189,000,000 68,000,000 1,181,000,000 -412,000,000 294,000,000 -120,000,000 2,001,000,000 5,511,000,000 -956,000,000 323,000,000 2,001,000,000 -242,000,000 1,433,000,000 302,000,000 412,000,000 2,469,000,000 -176,000,000 300,000,000 -12,000,000 2,753,000,000 -404,000,000 50,000,000 -185,000,000 2,440,000,000  612,700,000 -212,900,000 2,010,600,000  613,800,000 -1,364,200,000 2,712,200,000  892,000,000 162,000,000 1,584,800,000  593,400,000 100,400,000 672,200,000  344,600,000 -105,200,000 1,289,600,000  -136,800,000 -606,300,000 1,609,600,000  -510,500,000 247,000,000 1,976,900,000 
          adjustments to reconcile net earnings to net cash from operating activities:
                                                                                         
          impairments and loss on disposal of assets
         185,000,000 -14,000,000 2,000,000 33,000,000 -17,000,000 3,000,000 -1,000,000 12,000,000 84,000,000 1,000,000 537,000,000 367,000,000 20,000,000 710,000,000 153,000,000 286,000,000 471,000,000 1,295,000,000 -2,000,000 1,000,000 69,000,000 9,000,000 -1,000,000 7,000,000 1,000,000   67,000,000 1,000,000 1,355,000,000 50,000,000 9,000,000 3,000,000    3,000,000   -1,000,000   5,000,000 1,000,000   832,000,000 21,000,000 5,000,000 1,000,000 1,600,000                            
          provision for bad debts
         20,000,000 14,000,000 13,000,000 12,000,000 13,000,000 12,000,000 16,000,000 -23,000,000 16,000,000 14,000,000 29,000,000 20,000,000 20,000,000 30,000,000 29,000,000 22,000,000 21,000,000 13,000,000 12,000,000 16,000,000 14,000,000 19,000,000 16,000,000 20,000,000 39,000,000 18,000,000 29,000,000               16,000,000 14,000,000 12,000,000     13,000,000   1,000,000 15,300,000 5,000,000 800,000 900,000 5,000,000 14,400,000 5,100,000 2,700,000 -6,400,000 11,800,000 9,100,000 12,300,000 8,500,000 26,800,000 14,200,000 12,600,000 3,800,000 11,900,000 5,400,000 5,000,000 7,000,000 9,200,000 2,700,000 5,100,000 12,500,000 -200,000 7,400,000 9,000,000 
          increase in trade receivables
         -17,000,000   -466,000,000 -114,000,000   -734,000,000 225,000,000   -437,000,000 409,000,000 -411,000,000 -508,000,000  -864,000,000 -115,000,000 -214,000,000         -595,000,000 461,000,000 -258,000,000 -359,000,000 -239,000,000 -486,000,000 160,000,000 -306,000,000 -558,000,000 286,000,000 -87,000,000 -306,000,000             -71,000,000    -69,300,000    -272,300,000    -716,100,000 220,900,000 -716,200,000 628,900,000 -782,400,000 -17,900,000 -144,200,000   36,500,000 -227,500,000       
          increase in accounts payable
         -1,163,000,000 2,029,000,000 2,147,000,000 1,778,000,000 1,424,000,000 924,000,000 -1,394,000,000 -452,000,000 -2,170,000,000 2,719,000,000 1,727,000,000 245,000,000 -481,000,000 1,720,000,000 1,234,000,000 2,307,000,000 62,000,000 1,351,000,000 -292,000,000 1,058,000,000 -594,000,000 1,548,000,000 313,000,000 -610,000,000 525,000,000 1,735,000,000 -1,812,000,000 1,018,000,000 -1,261,000,000 811,000,000 1,296,000,000 939,000,000 72,000,000 1,284,000,000 279,000,000 339,000,000 -2,206,000,000 2,152,000,000 279,000,000   219,000,000       212,000,000 183,000,000 -433,000,000 464,000,000 -893,200,000 94,600,000 707,800,000 409,800,000 -629,900,000 223,600,000 729,700,000 1,033,100,000 -1,271,700,000 223,500,000 496,100,000 1,003,100,000 -886,500,000 340,000,000 312,900,000 982,600,000 -595,900,000 -37,300,000   -268,700,000 417,000,000 207,200,000 -131,100,000 46,100,000 965,800,000 33,700,000 470,500,000 
          repurchases of liability-classified specialty alliance units
         -5,000,000                                                                                
          net cash from operating activities
         1,823,000,000 686,000,000 973,000,000 1,527,000,000 2,917,000,000 -400,000,000 -1,647,000,000 2,077,000,000 -49,000,000 1,189,000,000 545,000,000 858,000,000 1,361,000,000 597,000,000 23,000,000 2,992,000,000 -419,000,000 1,195,000,000 -646,000,000 665,000,000 277,000,000 1,217,000,000 270,000,000 240,000,000 1,676,000,000 697,000,000 -653,000,000 506,000,000 756,000,000 279,000,000 1,181,000,000 554,000,000 1,556,000,000   724,000,000 -951,000,000   641,000,000 868,000,000 658,000,000 953,000,000 61,000,000 716,000,000 820,000,000 37,000,000 951,000,000 300,000,000 989,000,000 -130,000,000 568,000,000 -106,900,000 893,200,000 -114,500,000 504,200,000 119,800,000 914,000,000 143,800,000 217,000,000 324,200,000 879,300,000 524,600,000 406,000,000 827,700,000 820,900,000 271,600,000 -352,900,000 242,300,000 887,200,000 -26,200,000 408,800,000 -186,700,000 770,400,000 -78,900,000 718,300,000 483,600,000 271,800,000 660,900,000 724,000,000 
          capital expenditures
         -146,000,000 -131,000,000 -108,000,000 -232,000,000 -126,000,000 -99,000,000 -90,000,000 -193,000,000 -112,000,000 -114,000,000 -92,000,000 -217,000,000 -109,000,000 -85,000,000 -70,000,000 -164,000,000 -82,000,000 -74,000,000 -67,000,000 -126,000,000 -100,000,000 -96,000,000 -78,000,000 -136,000,000 -90,000,000 -77,000,000 -72,000,000 -136,000,000 -24,000,000 -101,000,000 -67,000,000 -138,000,000 -33,000,000   -94,000,000 -118,000,000   -181,000,000 -161,000,000 -56,000,000 -47,000,000 -36,000,000 -111,000,000 -48,000,000 -64,000,000 -26,000,000 -92,000,000 -41,000,000 -36,000,000 -26,000,000 -104,000,000 -57,700,000 -57,000,000 -44,300,000 -105,300,000 -59,900,000 -64,100,000 -62,000,000 -42,900,000 -37,000,000 -270,300,000 -80,900,000 -124,500,000 -79,500,000 -80,600,000 -91,500,000 -114,300,000 -89,100,000 -68,700,000 -85,300,000 -112,700,000 -112,300,000 -142,200,000 -76,000,000 
          free cash flows
         1,677,000,000 555,000,000 865,000,000 1,295,000,000 2,791,000,000 -499,000,000 -1,737,000,000 1,884,000,000 -161,000,000 1,075,000,000 453,000,000 641,000,000 1,252,000,000 512,000,000 -47,000,000 2,828,000,000 -501,000,000 1,121,000,000 -713,000,000 539,000,000 177,000,000 1,121,000,000 192,000,000 104,000,000 1,586,000,000 620,000,000 -725,000,000 370,000,000 732,000,000 178,000,000 1,114,000,000 416,000,000 1,523,000,000   630,000,000 -1,069,000,000   460,000,000 707,000,000 602,000,000 906,000,000 25,000,000 605,000,000 772,000,000 -27,000,000 925,000,000 208,000,000 948,000,000 -166,000,000 542,000,000 -210,900,000 835,500,000 -171,500,000 459,900,000 14,500,000 854,100,000 79,700,000 155,000,000 324,200,000 879,300,000 481,700,000 369,000,000 557,400,000 740,000,000 271,600,000 -352,900,000 117,800,000 807,700,000 -106,800,000 317,300,000 -301,000,000 681,300,000 -147,600,000 633,000,000 370,900,000 159,500,000 518,700,000 648,000,000 
          proceeds from disposal of property and equipment
               2,000,000 8,000,000 1,000,000 1,000,000 10,000,000 2,000,000                1,000,000                                                  
          proceeds from investments
             5,000,000   1,000,000  1,000,000  5,000,000 18,000,000 4,000,000  1,000,000 3,000,000 1,000,000                                                          
          proceeds from short-term investment in time deposit
                                                                                       
          payments to noncontrolling interests
                                                                                         
          effect of exchange rate changes on cash and equivalents
         1,000,000    4,000,000    -8,000,000 6,000,000 -5,000,000  14,000,000 -15,000,000  -2,000,000 -6,000,000 -5,000,000    -3,000,000    -8,000,000                                                      
          net increase in cash and equivalents
           719,000,000             2,361,000,000 -805,000,000   -92,000,000 -238,000,000   442,000,000 670,000,000 447,000,000 -1,319,000,000               302,000,000 412,000,000 -396,000,000 -176,000,000 300,000,000 -12,000,000 852,000,000 -404,000,000   166,000,000 -136,100,000   81,300,000 -32,500,000 613,800,000 -1,364,200,000 -43,100,000 116,500,000 892,000,000 162,000,000 363,200,000 481,500,000    -237,700,000   -19,200,000 442,300,000 -137,800,000 -471,700,000 288,700,000 -392,500,000 -509,300,000 247,000,000 575,700,000 
          payments of noncontrolling interests
                                                                                         
          net decrease in cash and equivalents
               -2,266,000,000    -189,000,000  336,000,000 162,000,000 -1,225,000,000    -944,000,000    -25,000,000       68,000,000 -5,698,000,000  -4,229,000,000 -120,000,000 -355,000,000    -355,000,000                            100,400,000 -619,100,000             
          decrease in trade receivables
           -539,000,000    288,000,000    50,000,000           -111,000,000 -388,000,000   -108,000,000 229,000,000               -427,000,000 -291,000,000 -548,000,000 53,000,000   135,000,000 -147,000,000                      -191,900,000    121,000,000  -733,300,000 160,000,000 -274,700,000 
          provision for deferred income taxes
                                                                                         
          decrease in inventories
                               -245,000,000    356,000,000                 199,000,000                     911,000,000   -873,600,000 499,400,000 367,300,000 -486,100,000 232,500,000 206,000,000 -172,700,000 66,300,000 117,800,000     
          proceeds from net investment hedge terminations
               6,000,000 28,000,000                                                                    
          purchase of short-term time deposits
                                                                                         
          purchases and payments of noncontrolling interests
                                                                                         
          net tax proceeds/(withholding) from share-based compensation
            -1,000,000 3,000,000                                                                            
          supplemental information:
                                                                                         
          cash payments for interest
                                                                                         
          net cash payments for income taxes
                                                                                         
          proceeds from divestitures, net of cash sold
             2,000,000                                                                        
          purchases of investments
             -3,000,000    -1,000,000 -1,000,000 -1,000,000  -1,000,000 -2,000,000 -3,000,000  -34,000,000 -2,000,000 -2,000,000                                                              
          impairments and loss on sale of investments
               1,000,000                                                                          
          gain on sale of equity interest in navihealth
                                                                                         
          loss on early extinguishment of debt
                        10,000,000 13,000,000                                                            
          purchase of investments
                             -1,000,000 -17,000,000  -12,000,000                                                        
          purchase of short-term investment in time deposit
                                                                                         
          purchase of noncontrolling interests
                                      -103,000,000 -3,000,000                                                 
          cash reclassified from/(to) assets held for sale
                                                                                         
          net cash payments/(refunds) for income taxes
                                                                                         
          purchases of short-term time deposits
                                                                                         
          net tax proceeds from share-based compensation
                 22,000,000                                                                        
          net tax withholdings from share-based compensation
                   -28,000,000    -14,000,000  1,000,000 1,000,000 -28,000,000  5,000,000 6,000,000 -12,000,000  7,000,000      -18,000,000    -9,000,000    -9,000,000                                          
          loss on sale of equity interest in navihealth
                        -1,000,000                                                                
          purchase of other investments
                                                                                         
          proceeds from sale of investments
                                                                                         
          proceeds from interest rate swap terminations
                                         14,000,000   14,000,000                                          
          net tax proceeds/(withholdings) from share-based compensation
                     2,000,000              -13,000,000                                                      
          cash and equivalents reclassified from assets held for sale
                                                                                         
          cash reclassified from assets held for sale
                          109,000,000                                                              
          net change in short-term borrowings
                                -683,000,000 683,000,000 -2,000,000   161,000,000 -6,000,000 -83,000,000 8,000,000 25,000,000 -22,000,000 -14,000,000 14,000,000 25,000,000 -8,000,000 -3,000,000 9,000,000 -58,000,000 40,000,000 49,000,000 -8,000,000 53,000,000 20,000,000 10,000,000 -28,000,000 27,000,000 -10,000,000 4,800,000 4,100,000 9,100,000 -5,000,000 4,900,000                        
          proceeds from divestitures, net of cash transferred, and disposal of property and equipment
                         -4,000,000 11,000,000 927,000,000                                                              
          cash and equivalents reclassified from/(to) assets held for sale
                                                                                         
          proceeds from divestitures, net of cash sold, and disposal of property and equipment
                                  14,000,000                                                    
          cash reclassified to assets held for sale
                                                                                         
          cash payments for income taxes
                                                                                         
          cash and equivalents reclassified to assets held for sale
                                                                                         
          net loss
                               -253,000,000                                                          
          adjustments to reconcile net loss to net cash from operating activities:
                                                                                         
          change in fair value of contingent consideration obligation
                                                           -17,800,000                            
          proceeds from sale of investments and available-for-sale securities
                                                                                         
          payment of contingent consideration obligation
                                      -2,000,000 -15,000,000 -13,000,000    20,000,000   -2,000,000 -4,000,000                                        
          loss on extinguishment of debt
                                 5,000,000     1,000,000 1,000,000                                             
          proceeds from return of investments
                                                                                         
          purchase of available-for-sale securities and other investments
                                   -3,000,000 -7,000,000 -5,000,000 -3,000,000 -3,000,000 -2,000,000 118,000,000   -6,000,000 -100,000,000    -208,000,000 -27,000,000 -32,000,000 -75,000,000                                     
          proceeds from sale of available-for-sale securities and other investments
                                   2,000,000 -62,000,000 1,000,000 64,000,000 -7,000,000 38,000,000 34,000,000 113,000,000 58,000,000 23,000,000 34,000,000 37,000,000 77,000,000 22,000,000 16,000,000 91,000,000                                     
          proceeds from maturities of available-for-sale securities
                                          22,000,000 17,000,000 28,000,000 30,000,000 2,000,000 17,000,000 13,000,000  8,000,000                                       
          excess tax benefits from share-based compensation
                                           30,000,000 -3,000,000   30,000,000                                         
          net cash provided by/(used in) investing activities
                                                                                         
          23
                                                                                         
          change in operating assets and liabilities, net of effects from acquisitions:
                                                                                         
          proceeds from divestitures and disposal of property and equipment and held for sale assets
                                            2,000,000                                             
          21
                                                                                         
          benefit from/(benefit from) deferred income taxes
                                                                                         
          net cash provided by/(used in) financing activities
                                                                                         
          47
                                                                                         
          net purchase of noncontrolling interests
                                          -2,000,000 -10,000,000   -10,000,000                                          
          tax proceeds from share-based compensation
                                                  14,000,000 4,000,000 38,000,000                                     
          19
                                                                                         
          purchase of available for sale securities and other investments
                                           -52,000,000    -52,000,000                                          
          earnings from discontinued operations, net of tax
                                                                                         
          earnings from continuing operations
                                                 292,000,000 365,000,000 289,000,000 266,000,000 234,000,000 315,000,000 274,000,000 340,000,000 -586,000,000 346,000,000 303,000,000 272,000,000 236,100,000 332,500,000 264,300,000 237,100,000 207,400,000 249,500,000 214,900,000 294,400,000 193,800,000 224,800,000 230,200,000 -61,800,000 260,700,000 313,400,000 318,900,000 249,800,000 321,600,000 366,000,000 325,100,000 303,200,000 237,700,000 -5,300,000 307,000,000 300,300,000  367,300,000 304,000,000 234,600,000 
          adjustments to reconcile earnings from continuing operations to net cash from operating activities:
                                                                                         
          (gain)/loss on sale of other investments
                                                                                         
          benefit from deferred income taxes
                                                                                         
          45
                                                                                         
          gain on sale of other investments
                                                 -5,000,000                                     
          proceeds from divestitures and disposal of held for sale assets
                                                                                       
          net proceeds/(tax withholdings) from share-based compensation
                                                                                         
          17
                                                                                         
          decrease/(increase) in trade receivables
                                                        1,395,000,000                                 
          decrease/(increase) in inventories
                                                        1,098,000,000                                 
          net proceeds from share-based compensation
                                                                                         
          earnings/(loss) from discontinued operations, net of tax
                                                                                         
          proceeds from maturities of available-for-sale securities and held-to-maturity securities
                                                                                         
          net proceeds from issuance of common shares
                                                 13,000,000 24,000,000 10,000,000 25,000,000 8,000,000 80,000,000   58,000,000                                
          tax proceeds/(disbursements) from share-based compensation
                                                     3,000,000 -3,000,000                                   
          loss from discontinued operations, net of tax
                                                           1,000,000                             
          decrease in accounts payable
                                                    -157,000,000                            -63,200,000         
          (earnings)/loss from discontinued operations, net of tax
                                                                                         
          gain on sale of investments
                                                                                        
          purchase of available-for-sale securities, held-to-maturity securities and other investments
                                                                                         
          proceeds from maturities of held-to-maturity securities
                                                         48,000,000 23,000,000 46,000,000 11,000,000 25,000,000 10,000,000                         
          (earnings)/income from discontinued operations, net of tax
                                                                                         
          proceeds from sale of other investments
                                                                                         
          table of contents
                                                                                         
          notes to condensed consolidated financial statements
                                                                                         
          income from discontinued operations, net of tax
                                                        1,000,000                                 
          proceeds from issuance of common shares
                                                        102,000,000   5,000,000 21,000,000 19,100,000 11,900,000 -7,100,000 18,100,000   2,500,000 8,400,000 15,500,000 -3,400,000 9,200,000 18,700,000 600,000 18,000,000 2,800,000 17,900,000 18,700,000 44,800,000 58,900,000 105,500,000 233,800,000 243,500,000 18,000,000 57,300,000 13,300,000 159,000,000 33,700,000 34,800,000 
          net tax disbursements from share-based compensation
                                                        -15,000,000                                 
          gain on sale of investment in carefusion
                                                                 -3,800,000 3,300,000 -74,800,000                     
          purchase of held-to-maturity securities and other investments
                                                             -24,500,000                           
          proceeds from sale of property and equipment
                                                                  100,000 2,700,000 100,000  1,500,000 -500,000 4,800,000 900,000 300,000   22,300,000 2,900,000 4,900,000 2,500,000 5,500,000 -9,600,000 9,500,000 3,800,000 6,400,000 3,600,000 7,100,000 500,000 
          proceeds from sale of carefusion common stock
                                                                     135,700,000                   
          tax disbursements from share-based compensation
                                                           10,000,000 -22,000,000    -21,600,000    -14,100,000                     
          adjustments to reconcile earnings from continuing operations to net cash from operations:
                                                                                         
          (earnings)/loss from discontinued operations
                                                               2,300,000 300,000                         
          net cash from operating activities—continuing operations
                                                             -106,900,000 893,200,000 -114,500,000 504,200,000 119,800,000 914,200,000 143,400,000 217,700,000                     
          net cash from operating activities—discontinued operations
                                                                 -200,000 400,000 -700,000                     
          proceeds from divestitures and sale of property and equipment
                                                                                         
          net cash from investing activities—continuing operations
                                                               -42,500,000 -41,600,000 -100,200,000 -74,400,000 -1,937,500,000 84,100,000                     
          net cash from investing activities—discontinued operations
                                                                                         
          payment of contingent consideration
                                                                                         
          payment of premiums for debt extinguishment
                                                                       -66,400,000                 
          tax disbursements from exercises of stock options
                                                                 -5,000,000 -5,800,000                       
          net cash from financing activities—continuing operations
                                                               -55,900,000 -381,300,000 -52,100,000 -225,800,000 429,500,000 -344,200,000                     
          net cash from financing activities—discontinued operations
                                                                                         
          cash and equivalents at beginning of year
                                                                                         
          cash and equivalents at end of year
                                                                                         
          non-cash investing and financing transactions for:
                                                                                         
          retained investment in carefusion at date of spin-off
                                                                                         
          non-cash dividend in connection with spin-off
                                                                     -68,600,000 29,600,000 3,728,400,000                 
          loss from discontinued operations
                                                                          600,000 2,400,000 700,000    1,400,000    29,600,000 17,800,000    
          proceeds from sale of investment in carefusion
                                                                  705,900,000                     
          tax proceeds/(disbursements) from exercises of stock options
                                                              3,300,000      2,000,000                     
          impairments and loss on sale of assets
                                                               1,100,000 1,300,000 400,000 4,600,000 1,700,000 1,900,000 900,000 4,200,000 400,000 23,600,000                 
          excess tax benefit from exercises of stock options
                                                                4,900,000                         
          purchase of held-to-maturity investment securities
                                                                 -14,600,000                       
          cash payments for:
                                                                                         
          interest
                                                                                         
          income taxes
                                                                                         
          (earnings)/ loss from discontinued operations
                                                                                         
          acquisition of subsidiaries, net of divestitures and cash acquired
                                                                       -32,000,000   -100,000 -6,100,000 -475,900,000 200,000 48,900,000 -88,100,000 -1,480,800,000 -28,000,000 -76,600,000 -44,400,000 -256,600,000 -33,100,000   
          issuance of common shares
                                                                                         
          earnings from discontinued operations
                                                                   -500,000 -400,000   -4,300,000 -23,600,000                 
          gain on sale of carefusion common stock
                                                                                         
          proceeds from divestitures
                                                                                         
          net additions to property and equipment
                                                                            -88,600,000             
          sale of investment securities available for sale
                                                                             100,000 131,900,000 168,100,000 167,100,000 -10,600,000 41,900,000     
          share-based payment compensation
                                                                                         
          net cash from operating activities – continuing operations
                                                                      878,200,000 522,200,000 261,600,000  821,600,000 273,900,000 -352,000,000  897,200,000 -24,100,000 439,200,000  685,800,000 -113,300,000 722,100,000     
          net cash from operating activities – discontinued operations
                                                                      1,100,000 2,400,000 144,400,000  -700,000 -2,300,000 -900,000  -10,000,000 -2,100,000 -30,400,000  84,600,000 34,400,000 -3,800,000     
          net cash from investing activities – continuing operations
                                                                      88,100,000 91,600,000 -64,200,000  -92,900,000 -81,400,000 -94,700,000  -76,400,000 -26,800,000 -45,200,000  40,400,000 -146,400,000 -84,000,000     
          net cash from investing activities – discontinued operations
                                                                       -9,900,000          -72,200,000 -8,000,000 100,000     
          tax expense from stock options
                                                                                         
          net cash from financing activities – continuing operations
                                                                       -454,200,000 -1,252,500,000  -134,600,000 -89,800,000 -171,500,000  -466,200,000 -52,200,000 -382,800,000  -853,800,000 -232,200,000 -327,900,000     
          net cash from financing activities – discontinued operations
                                                                      1,283,800,000          -22,600,000 -6,200,000 -17,800,000     
          supplemental information
                                                                                         
          investment in carefusion
                                                                      2,300,000 860,800,000                 
          share based payment compensation
                                                                                         
          net change in commercial paper and short-term borrowings
                                                                          -100,100,000 99,900,000 1,200,000 -202,700,000 -317,200,000 287,400,000 232,000,000 -293,400,000 250,800,000 -97,700,000 101,400,000 -30,900,000 -1,700,000 3,000,000 3,000,000 
          tax benefit from stock options
                                                                       100,000 -6,200,000                 
          loss on debt extinguishment
                                                                        39,900,000                 
          equity compensation
                                                                        22,000,000 30,500,000 33,100,000 34,800,000 24,400,000 35,600,000 32,200,000 28,400,000 26,100,000 28,800,000 38,900,000 25,400,000 45,000,000 52,100,000 46,500,000 55,800,000 82,900,000 
          asset impairments and loss on sale of assets
                                                                         11,500,000   3,600,000             
          acquired in-process research and development
                                                                                         
          increase in net investment in sales-type leases
                                                                         8,100,000 -1,300,000 -14,800,000 -20,200,000 -41,100,000 -25,200,000 -34,500,000 -24,100,000 -53,800,000 -32,700,000 -23,400,000 -20,900,000 -31,000,000 -20,200,000 -23,100,000 -38,800,000 
          tax benefit from exercises of stock options
                                                                                         
          acquisition of businesses, net of divestitures and cash acquired
                                                                                         
          purchase of common shares in treasury
                                                                                         
          impairments, loss on sale of assets and other
                                                                                         
          tax benefits from exercises of stock options
                                                                           -1,000,000 3,300,000 26,800,000 1,300,000 2,400,000 11,600,000 1,200,000 11,600,000 3,100,000 14,000,000 6,300,000 21,400,000   
          (earnings) / loss from discontinued operations
                                                                              9,900,000           
          asset impairments and other
                                                                              2,400,000           
          purchase common shares in treasury
                                                                                         
          increase in other accrued liabilities and operating items
                                                                                         
          asset impairments
                                                                                -200,000 1,200,000 3,600,000 10,800,000 3,600,000 1,900,000 16,700,000 3,000,000 2,500,000 
          net cash from operating activities — continuing operations
                                                                                         
          net cash from operating activities — discontinued operations
                                                                                         
          net cash from investing activities — continuing operations
                                                                                         
          net cash from investing activities — discontinued operations
                                                                                         
          net cash from financing activities — continuing operations
                                                                                         
          net cash from financing activities — discontinued operations
                                                                                         
          cumulative effect of change in accounting
                                                                                         
          earnings from continuing operations before cumulative effect of change in accounting
                                                                                         
          adjustments to reconcile earnings from continuing operations before cumulative effect of change in accounting to net cash from operations:
                                                                                         
          net cash from operating activities - continuing operations
                                                                                         
          net cash from operating activities - discontinued operations
                                                                                         
          purchase of investment securities available for sale
                                                                                     800,000 -80,200,000 -219,200,000 -100,000,000 
          net cash from investing activities - continuing operations
                                                                                         
          net cash from investing activities - discontinued operations
                                                                                         
          net cash from financing activities - continuing operations
                                                                                         
          net cash from financing activities - discontinued operations
                                                                                         
          proceeds from sale of discontinued operations
                                                                                         
          divestiture/(acquisition) of subsidiaries, net of cash acquired
                                                                                        3,300,000 
          tax benefits from exercises of stock options and other
                                                                                        9,400,000 
          decrease in net investment in sales-type leases